data_1bjb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1bjb _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 24.7 p90 . . . . . 0 N--CA 1.504 2.241 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -164.26 7.81 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.029 0.443 . . . . 0.0 111.325 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.0 t 69.61 -42.48 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 126.011 2.07 . . . . 0.0 114.694 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.9 m170 75.48 40.17 0.32 Allowed 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -139.07 -28.3 0.79 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 112.963 -1.926 . . . . 0.0 110.697 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -117.92 -41.28 2.91 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 124.579 1.174 . . . . 0.0 110.956 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.522 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 27.5 tt0 -59.13 -40.41 85.36 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 117.312 -1.755 . . . . 0.0 111.208 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.92 -15.25 61.58 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.627 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.7 t -76.29 -47.72 29.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.478 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.522 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -72.49 -28.23 62.76 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 113.112 -1.858 . . . . 0.0 107.565 -179.499 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -72.22 -40.43 67.79 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.6 -45.97 87.95 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -65.28 -25.15 67.52 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 124.746 1.279 . . . . 0.0 111.151 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.57 -50.03 48.61 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.7 t -59.89 -47.6 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 159.76 -55.41 0.34 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 104.016 -3.634 . . . . 0.0 104.016 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.8 m -170.11 36.47 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 55.71 30.37 15.46 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 114.252 -1.34 . . . . 0.0 110.689 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm . . . . . 0 N--CA 1.504 2.274 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.662 -179.816 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 13.3 p90 . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -83.8 117.85 23.55 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 113.67 -1.604 . . . . 0.0 109.993 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.7 t -91.83 -55.69 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-N 112.283 -2.235 . . . . 0.0 112.383 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 76.23 -2.5 2.72 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 125.355 1.659 . . . . 0.0 112.548 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -77.33 -50.37 12.96 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.794 0.807 . . . . 0.0 109.787 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -124.82 -31.03 3.21 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 112.695 -2.048 . . . . 0.0 108.454 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -46.01 -51.25 13.91 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 124.803 1.314 . . . . 0.0 110.493 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.4 pp -82.69 -15.21 52.83 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 117.701 -1.6 . . . . 0.0 112.75 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.5 t -72.59 -18.9 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -75.21 -14.01 60.5 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.944 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -103.03 -49.43 3.76 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.8 -15.06 57.8 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 113.992 -1.458 . . . . 0.0 107.122 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.42 -48.65 69.33 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -70.27 -59.28 2.97 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 113.449 -1.705 . . . . 0.0 112.369 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 t -59.68 -38.79 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.056 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.98 -51.92 54.37 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.0 t -55.39 -49.09 73.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 124.524 0.779 . . . . 0.0 109.918 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -50.91 -56.09 14.0 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 124.635 1.209 . . . . 0.0 110.015 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.2 mttp . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 116.59 -1.671 . . . . 0.0 110.436 179.759 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.413 ' CG ' ' N ' ' A' ' 11' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 122.029 0.919 . . . . 0.0 110.081 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.413 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -172.44 141.72 1.21 Allowed 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 112.917 -1.947 . . . . 0.0 105.877 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.5 t -143.01 -59.75 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.915 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 65.31 -2.13 0.83 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 124.425 1.078 . . . . 0.0 112.299 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -89.6 -97.76 0.1 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 103.123 -2.917 . . . . 0.0 103.123 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -58.74 -28.5 65.92 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.417 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 34.0 tt0 -45.1 -48.94 11.99 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 113.545 -1.661 . . . . 0.0 112.477 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mt -86.35 -23.52 26.18 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.936 0.874 . . . . 0.0 109.551 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.6 t -69.23 -15.45 19.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.417 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 22.7 m-85 -74.61 -22.98 58.66 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -86.01 -45.26 11.62 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 104.697 -2.334 . . . . 0.0 104.697 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.74 -31.41 68.29 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -65.28 -40.62 94.12 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 114.175 -1.375 . . . . 0.0 109.209 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.16 -49.27 74.99 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.096 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.1 t -53.28 -54.09 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 124.692 1.245 . . . . 0.0 108.609 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 157.12 -57.9 0.37 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 106.551 -2.62 . . . . 0.0 106.551 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.0 t -167.77 47.91 0.05 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 61.1 17.01 7.64 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.246 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 116.281 -1.819 . . . . 0.0 111.502 -179.926 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.9 p90 . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -118.87 135.43 54.56 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.441 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.428 ' CG1' ' H ' ' A' ' 14' ' ' HIS . 2.6 t -138.03 -54.21 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-N 113.593 -1.64 . . . . 0.0 111.61 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.3 m170 78.76 -5.08 2.07 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 125.05 1.469 . . . . 0.0 112.933 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.428 ' H ' ' CG1' ' A' ' 12' ' ' VAL . 22.8 m-70 -98.26 -98.65 0.21 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -60.08 -19.35 52.76 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.426 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 27.7 tt0 -47.66 -52.44 18.15 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.553 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 pp -79.48 -18.93 50.96 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.352 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.6 t -71.05 -19.87 21.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.426 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 15.8 m-85 -76.06 -23.13 55.05 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -83.09 -49.93 9.02 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.1 -34.13 73.06 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -58.76 -41.81 87.45 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 113.886 -1.506 . . . . 0.0 110.064 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.72 -48.96 43.59 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.878 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.7 t -51.05 -52.71 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 124.411 1.07 . . . . 0.0 110.376 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 145.43 -133.15 4.93 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.1 m -147.84 46.8 1.1 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 61.08 9.22 2.28 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.949 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt . . . . . 0 N--CA 1.5 2.056 0 CA-C-O 117.582 -1.199 . . . . 0.0 112.397 -179.891 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 121.442 0.639 . . . . 0.0 112.568 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.92 100.51 8.1 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 42.8 t -55.32 -66.95 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 112.321 -2.218 . . . . 0.0 111.998 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 58.29 7.07 0.61 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 124.099 0.874 . . . . 0.0 112.704 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -87.7 -76.19 0.39 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -85.77 -24.87 26.69 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 113.566 -1.652 . . . . 0.0 107.725 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.424 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 25.8 tt0 -46.25 -50.36 16.06 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 114.217 -1.356 . . . . 0.0 110.605 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.41 -22.18 48.16 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.274 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.4 t -70.61 -19.67 21.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.424 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 14.3 m-30 -75.08 -24.03 58.09 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.83 -49.2 9.94 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.45 -33.39 69.67 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -61.47 -40.26 93.89 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.921 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.92 -48.59 57.94 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 124.567 1.167 . . . . 0.0 108.907 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 44.5 t -52.62 -53.2 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 124.652 1.22 . . . . 0.0 110.553 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 173.48 37.9 0.04 OUTLIER Glycine 0 N--CA 1.496 2.652 0 C-N-CA 119.898 -1.144 . . . . 0.0 112.942 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 78.3 p 42.52 27.67 0.1 Allowed 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -151.25 -70.12 0.17 Allowed 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 116.923 -1.513 . . . . 0.0 108.826 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.454 ' C ' ' H ' ' A' ' 13' ' ' HIS . 0.9 OUTLIER -158.29 21.25 0.24 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 123.603 0.564 . . . . 0.0 112.057 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.0 t 72.49 -34.66 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 125.747 1.905 . . . . 0.0 112.027 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.454 ' H ' ' C ' ' A' ' 11' ' ' GLU . 6.5 m170 74.86 38.07 0.48 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -137.56 -79.54 0.37 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 112.909 -1.95 . . . . 0.0 107.231 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -51.77 -47.74 64.04 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.406 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.48 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 27.7 tt0 -49.64 -34.74 19.08 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.106 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 mt -81.41 -28.35 34.35 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 114.847 -1.069 . . . . 0.0 111.723 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.4 t -65.68 -26.92 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 C-N-CA 118.475 -1.29 . . . . 0.0 107.577 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.48 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 4.7 m-30 -71.37 -26.98 63.02 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 113.76 -1.564 . . . . 0.0 107.672 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -78.97 -47.99 15.31 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.86 -26.92 69.0 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -72.52 -22.7 60.99 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 118.714 -1.194 . . . . 0.0 111.763 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -99.22 -44.02 6.4 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 124.055 0.847 . . . . 0.0 113.193 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.9 t -102.72 -28.41 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 123.954 0.784 . . . . 0.0 112.24 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 41.23 61.19 2.11 Favored Glycine 0 N--CA 1.504 3.204 0 O-C-N 123.974 0.796 . . . . 0.0 113.142 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.9 p -149.07 -84.1 0.1 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 123.954 0.443 . . . . 0.0 110.607 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -81.69 -1.98 48.82 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 123.692 0.62 . . . . 0.0 111.055 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.503 2.215 0 CA-C-O 115.305 -2.283 . . . . 0.0 114.068 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.466 ' CG ' ' N ' ' A' ' 11' ' ' GLU . 6.3 p90 . . . . . 0 N--CA 1.503 2.207 0 CA-C-O 121.339 0.59 . . . . 0.0 112.216 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.466 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 20.2 mt-10 39.11 106.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 126.043 2.089 . . . . 0.0 116.311 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.3 t -126.93 -63.77 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-N 112.94 -1.936 . . . . 0.0 106.328 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.406 ' CD2' ' N ' ' A' ' 13' ' ' HIS . 12.1 m170 82.11 7.66 0.95 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 125.958 2.036 . . . . 0.0 112.024 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 -104.68 -78.16 0.57 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 103.7 -2.704 . . . . 0.0 103.7 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -63.66 -17.67 63.17 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.658 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.62 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 32.0 tt0 -60.95 -48.59 81.1 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.596 -1.183 . . . . 0.0 110.621 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.04 -19.51 61.83 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.203 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.6 t -76.36 -41.79 36.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.868 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.62 ' CE2' ' HA ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -78.6 -19.79 51.95 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 125.28 1.613 . . . . 0.0 108.747 -179.595 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -79.91 -41.62 25.76 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.38 -33.67 74.68 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.77 -27.56 64.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 124.938 1.399 . . . . 0.0 108.826 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -78.25 -54.33 6.34 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.894 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.1 t -78.16 -3.98 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 123.722 0.639 . . . . 0.0 110.466 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.02 74.45 0.34 Allowed Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.8 p 48.78 34.92 5.68 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 125.019 1.07 . . . . 0.0 111.124 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 58.14 61.52 2.3 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.494 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 116.779 -1.582 . . . . 0.0 110.444 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 114.079 1.141 . . . . 0.0 114.079 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.04 138.3 42.04 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 113.288 -1.778 . . . . 0.0 109.03 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 42.5 t -153.86 -60.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.473 ' N ' ' CD2' ' A' ' 13' ' ' HIS . 8.3 m170 74.87 -18.28 0.44 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 125.748 1.905 . . . . 0.0 113.166 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -57.31 -43.28 83.14 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.506 0.669 . . . . 0.0 109.392 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.1 -30.61 2.42 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 113.242 -1.799 . . . . 0.0 106.661 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.409 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 42.6 tt0 -50.32 -48.23 55.43 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.191 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.26 -20.45 48.1 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.469 -1.292 . . . . 0.0 110.738 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.5 t -70.49 -19.34 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.409 ' CE2' ' HA ' ' A' ' 16' ' ' GLU . 16.9 m-30 -72.41 -25.02 61.32 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -82.15 -48.2 11.6 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.07 -25.35 65.32 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.19 -38.47 60.8 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 125.331 1.644 . . . . 0.0 108.35 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.08 -48.04 75.16 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.5 t -70.02 -17.7 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.382 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.69 52.77 48.54 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.1 t 53.13 30.39 9.67 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 124.564 0.803 . . . . 0.0 111.19 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 72.61 56.12 0.14 Allowed 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.713 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.985 0 CA-C-N 113.268 -1.787 . . . . 0.0 107.881 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.927 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.95 162.62 29.28 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.288 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.0 t -143.55 -54.46 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.592 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 78.64 24.66 0.57 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 126.231 2.207 . . . . 0.0 112.346 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -119.3 -94.07 0.51 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 101.726 -3.435 . . . . 0.0 101.726 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -62.74 -20.9 65.39 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -47.93 -52.18 20.56 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.896 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.65 -16.68 55.32 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.766 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.9 t -72.19 -21.38 20.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -75.95 -23.95 55.44 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -80.74 -47.7 13.58 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.34 -40.18 81.46 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.64 -36.99 80.03 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 113.489 -1.687 . . . . 0.0 109.828 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.05 -49.38 65.33 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.55 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.7 t -54.31 -53.98 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 124.42 1.075 . . . . 0.0 109.526 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.96 -35.9 2.53 Favored Glycine 0 N--CA 1.496 2.672 0 O-C-N 124.053 0.846 . . . . 0.0 112.807 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.0 m -57.59 -31.71 66.46 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.107 0.479 . . . . 0.0 111.181 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -107.37 -7.09 16.78 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.103 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.826 0 O-C-N 124.505 1.128 . . . . 0.0 109.355 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.6 p90 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -134.04 109.14 8.77 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 122.206 1.003 . . . . 0.0 110.603 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.7 t -129.14 -60.69 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-N 112.384 -2.189 . . . . 0.0 106.323 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.444 ' N ' ' CD2' ' A' ' 13' ' ' HIS . 6.8 m170 75.66 0.19 3.34 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 125.48 1.738 . . . . 0.0 111.943 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -93.81 -88.95 0.22 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -56.39 -27.05 55.13 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.441 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 24.4 tt0 -48.84 -48.03 42.11 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 114.072 -1.422 . . . . 0.0 109.151 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.51 -20.81 46.32 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 124.169 0.918 . . . . 0.0 111.858 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.7 t -70.27 -21.98 23.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.441 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 11.5 m-30 -74.39 -23.16 58.93 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -81.82 -44.19 17.26 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.35 -38.74 81.16 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -59.89 -36.9 77.93 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.525 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.59 -50.32 52.55 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.8 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.4 t -53.0 -56.54 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 124.55 1.157 . . . . 0.0 109.507 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.45 -1.24 0.3 Allowed Glycine 0 N--CA 1.499 2.839 0 O-C-N 124.073 0.858 . . . . 0.0 115.221 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.7 m -75.63 -93.96 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -66.57 -18.97 65.66 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.6 mmtt . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 116.466 -1.731 . . . . 0.0 108.89 179.87 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 120.896 0.379 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -141.49 128.82 21.13 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 t -131.33 -62.23 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.067 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.406 ' CD2' ' N ' ' A' ' 13' ' ' HIS . 7.4 m170 77.3 -22.72 0.27 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 125.328 1.643 . . . . 0.0 110.795 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 29.7 m-70 -75.17 -95.9 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.37 -27.23 62.11 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.473 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 29.2 tt0 -49.98 -46.15 52.26 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 113.889 -1.505 . . . . 0.0 108.955 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.52 -23.38 46.31 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.27 -0.972 . . . . 0.0 111.145 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.0 t -70.9 -17.15 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.473 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 15.0 m-30 -75.98 -15.6 60.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 124.437 1.085 . . . . 0.0 108.135 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -96.9 -48.53 5.4 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.39 -16.52 55.23 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 114.038 -1.437 . . . . 0.0 107.403 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.46 -45.89 78.23 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -65.52 -48.07 73.78 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 114.007 -1.451 . . . . 0.0 107.969 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.5 t -59.23 -21.65 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.583 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.24 48.02 55.1 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 46.4 p 47.09 27.74 0.82 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 124.945 1.027 . . . . 0.0 112.828 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 54.28 62.38 2.6 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 114.757 -1.111 . . . . 0.0 110.884 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.9 mtpp . . . . . 0 N--CA 1.499 2.019 0 CA-C-O 116.311 -1.804 . . . . 0.0 111.169 179.935 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.809 0.814 . . . . 0.0 112.42 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -153.15 148.76 27.31 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 t -139.16 -50.59 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 124.042 0.839 . . . . 0.0 110.917 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.9 m170 73.73 -7.35 1.6 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 124.583 1.177 . . . . 0.0 112.651 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 -95.46 -97.63 0.17 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 103.468 -2.79 . . . . 0.0 103.468 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -55.83 -23.48 30.72 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.469 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 34.4 tt0 -48.29 -44.0 33.32 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 114.063 -1.426 . . . . 0.0 110.978 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.46 -24.39 27.44 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.632 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.6 t -69.4 -16.65 20.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.469 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 19.3 m-30 -75.31 -22.9 57.34 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -83.94 -48.13 10.3 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.3 -27.56 68.57 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -63.15 -42.37 99.45 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.474 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.77 -47.84 73.84 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.639 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 82.6 t -51.74 -52.32 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 124.688 1.243 . . . . 0.0 109.427 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.82 25.93 1.47 Allowed Glycine 0 N--CA 1.496 2.661 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.8 m 42.09 22.83 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 50.59 29.47 4.11 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.419 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 116.129 -1.891 . . . . 0.0 111.526 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 43.9 p90 . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 120.991 0.424 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.23 26.36 0.1 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 118.045 2.609 . . . . 0.0 118.045 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.0 t 72.59 -58.27 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 125.525 1.766 . . . . 0.0 112.268 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 11.9 m170 90.41 -5.42 0.31 Allowed 'General case' 0 N--CA 1.505 2.281 0 O-C-N 126.336 2.273 . . . . 0.0 113.574 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.49 ' N ' ' CD2' ' A' ' 14' ' ' HIS . 0.0 OUTLIER -124.77 -65.86 1.01 Allowed 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.702 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -54.37 -27.5 36.84 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.621 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.597 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 25.9 tt0 -64.29 -45.08 89.55 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.053 -1.059 . . . . 0.0 109.456 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.6 -20.95 62.71 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.832 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.9 t -75.14 -45.9 40.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.694 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.597 ' CE2' ' HA ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -76.25 -19.05 58.69 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.228 -1.351 . . . . 0.0 108.959 -179.621 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -80.52 -39.43 27.86 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.4 -42.7 95.96 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.64 -35.39 76.07 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 113.628 -1.624 . . . . 0.0 109.524 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.16 -51.72 50.24 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.512 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.5 t -51.74 -50.22 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 124.129 0.893 . . . . 0.0 109.784 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.17 41.02 9.67 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.0 p -131.12 -34.5 1.44 Allowed 'General case' 0 N--CA 1.499 1.975 0 CA-C-N 114.22 -0.99 . . . . 0.0 109.203 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.43 ' H ' ' ND2' ' A' ' 27' ' ' ASN . 0.0 OUTLIER -113.71 -17.46 12.1 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 113.315 -1.766 . . . . 0.0 108.571 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp . . . . . 0 N--CA 1.498 1.942 0 CA-C-O 114.788 -2.529 . . . . 0.0 110.96 179.94 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.7 p90 . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 120.588 0.232 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -76.77 138.91 40.19 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 124.254 0.971 . . . . 0.0 110.497 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.4 t -127.18 -56.68 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 113.219 -1.809 . . . . 0.0 107.569 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 12.0 m170 89.41 -2.25 0.36 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 126.852 2.595 . . . . 0.0 110.524 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 -100.9 -98.21 0.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 103.549 -2.76 . . . . 0.0 103.549 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -53.87 -25.2 18.7 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.446 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 29.1 tt0 -46.73 -47.71 20.55 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.139 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.98 -24.45 32.93 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.296 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.9 t -68.88 -18.7 23.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.446 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 17.9 m-85 -74.83 -23.65 58.48 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -84.71 -48.39 9.49 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.56 -34.58 71.21 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -57.6 -42.58 83.51 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.075 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.68 -51.9 50.88 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.392 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.3 t -51.78 -51.61 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 124.726 1.266 . . . . 0.0 111.038 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -38.22 101.23 0.01 OUTLIER Glycine 0 N--CA 1.498 2.786 0 O-C-N 124.337 1.023 . . . . 0.0 113.583 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.8 t 40.23 36.51 0.33 Allowed 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 114.394 -0.903 . . . . 0.0 113.331 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.9 p30 40.64 31.62 0.12 Allowed 'General case' 0 N--CA 1.504 2.248 0 O-C-N 124.354 1.034 . . . . 0.0 113.659 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt . . . . . 0 N--CA 1.502 2.126 0 CA-C-O 117.936 -1.031 . . . . 0.0 113.109 -179.883 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.3 t70 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.117 0.484 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.36 -82.11 0.21 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 102.745 -3.057 . . . . 0.0 102.745 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -162.97 91.97 0.75 Allowed 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -173.87 -15.68 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 113.145 -1.843 . . . . 0.0 109.285 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.01 45.83 1.76 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -150.66 -48.54 0.12 Allowed 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 111.565 -2.562 . . . . 0.0 109.207 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -150.13 32.25 0.67 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.489 0.662 . . . . 0.0 109.945 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.31 41.25 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.746 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 146.13 51.31 0.03 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 107.074 -2.41 . . . . 0.0 107.074 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 24.7 p90 36.29 -146.32 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 O-C-N 125.222 1.19 . . . . 0.0 112.793 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -164.26 7.81 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.029 0.443 . . . . 0.0 111.325 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.0 t 69.61 -42.48 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 126.011 2.07 . . . . 0.0 114.694 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.9 m170 75.48 40.17 0.32 Allowed 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -139.07 -28.3 0.79 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 112.963 -1.926 . . . . 0.0 110.697 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -117.92 -41.28 2.91 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 124.579 1.174 . . . . 0.0 110.956 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.522 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 27.5 tt0 -59.13 -40.41 85.36 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 117.312 -1.755 . . . . 0.0 111.208 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.92 -15.25 61.58 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.627 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.7 t -76.29 -47.72 29.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.478 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.522 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -72.49 -28.23 62.76 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 113.112 -1.858 . . . . 0.0 107.565 -179.499 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -72.22 -40.43 67.79 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.6 -45.97 87.95 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -65.28 -25.15 67.52 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 124.746 1.279 . . . . 0.0 111.151 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.57 -50.03 48.61 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.7 t -59.89 -47.6 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 159.76 -55.41 0.34 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 104.016 -3.634 . . . . 0.0 104.016 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.8 m -170.11 36.47 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 55.71 30.37 15.46 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 114.252 -1.34 . . . . 0.0 110.689 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm . . . . . 0 N--CA 1.504 2.274 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.662 -179.816 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.583 0.706 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.79 -95.09 0.06 Allowed 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.168 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -156.34 83.44 0.98 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.448 ' C ' ' H ' ' A' ' 6' ' ' HIS . 94.8 m-85 -147.95 -62.91 0.26 Allowed 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 103.865 -2.643 . . . . 0.0 103.865 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.45 ' NE ' ' CD2' ' A' ' 6' ' ' HIS . 0.0 OUTLIER -76.28 8.1 3.67 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.288 -1.323 . . . . 0.0 111.59 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.45 ' CD2' ' NE ' ' A' ' 5' ' ' ARG . 28.6 m170 -99.95 -49.68 4.25 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 112.958 -1.928 . . . . 0.0 111.615 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.86 35.2 0.05 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 123.928 0.767 . . . . 0.0 111.757 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.37 36.88 0.11 Allowed 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 122.36 1.076 . . . . 0.0 108.437 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 146.05 15.23 0.18 Allowed Glycine 0 N--CA 1.495 2.609 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -70.13 173.99 5.98 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -83.8 117.85 23.55 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 113.67 -1.604 . . . . 0.0 109.993 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.7 t -91.83 -55.69 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-N 112.283 -2.235 . . . . 0.0 112.383 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 76.23 -2.5 2.72 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 125.355 1.659 . . . . 0.0 112.548 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -77.33 -50.37 12.96 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.794 0.807 . . . . 0.0 109.787 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -124.82 -31.03 3.21 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 112.695 -2.048 . . . . 0.0 108.454 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -46.01 -51.25 13.91 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 124.803 1.314 . . . . 0.0 110.493 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.4 pp -82.69 -15.21 52.83 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 117.701 -1.6 . . . . 0.0 112.75 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.5 t -72.59 -18.9 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -75.21 -14.01 60.5 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.944 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -103.03 -49.43 3.76 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.8 -15.06 57.8 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 113.992 -1.458 . . . . 0.0 107.122 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.42 -48.65 69.33 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -70.27 -59.28 2.97 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 113.449 -1.705 . . . . 0.0 112.369 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 t -59.68 -38.79 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.056 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.98 -51.92 54.37 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.0 t -55.39 -49.09 73.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 124.524 0.779 . . . . 0.0 109.918 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -50.91 -56.09 14.0 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 124.635 1.209 . . . . 0.0 110.015 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.2 mttp . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 116.59 -1.671 . . . . 0.0 110.436 179.759 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.133 0.492 . . . . 0.0 109.842 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.69 -61.63 1.9 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 105.82 -1.919 . . . . 0.0 105.82 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.416 ' HA ' ' CE1' ' A' ' 6' ' ' HIS . 0.0 OUTLIER -177.67 7.03 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 124.695 1.247 . . . . 0.0 113.053 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 5' ' ' ARG . 19.2 p90 -78.56 -46.28 19.8 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.275 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.403 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 16.6 ttm180 -48.05 -21.22 0.43 Allowed 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.416 ' CE1' ' HA ' ' A' ' 3' ' ' GLU . 40.2 m170 -55.28 -44.66 75.87 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 111.376 -2.647 . . . . 0.0 112.7 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -174.39 15.59 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.8 m -147.04 32.99 0.91 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 114.329 -1.305 . . . . 0.0 108.319 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -121.68 -41.38 0.49 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.413 ' CG ' ' N ' ' A' ' 11' ' ' GLU . 0.3 OUTLIER -141.57 -179.73 6.33 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 122.029 0.919 . . . . 0.0 110.081 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.413 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -172.44 141.72 1.21 Allowed 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 112.917 -1.947 . . . . 0.0 105.877 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.5 t -143.01 -59.75 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.915 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 65.31 -2.13 0.83 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 124.425 1.078 . . . . 0.0 112.299 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -89.6 -97.76 0.1 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 103.123 -2.917 . . . . 0.0 103.123 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -58.74 -28.5 65.92 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.417 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 34.0 tt0 -45.1 -48.94 11.99 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 113.545 -1.661 . . . . 0.0 112.477 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mt -86.35 -23.52 26.18 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.936 0.874 . . . . 0.0 109.551 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.6 t -69.23 -15.45 19.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.417 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 22.7 m-85 -74.61 -22.98 58.66 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -86.01 -45.26 11.62 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 104.697 -2.334 . . . . 0.0 104.697 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.74 -31.41 68.29 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -65.28 -40.62 94.12 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 114.175 -1.375 . . . . 0.0 109.209 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.16 -49.27 74.99 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.096 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.1 t -53.28 -54.09 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 124.692 1.245 . . . . 0.0 108.609 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 157.12 -57.9 0.37 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 106.551 -2.62 . . . . 0.0 106.551 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.0 t -167.77 47.91 0.05 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 61.1 17.01 7.64 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.246 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 116.281 -1.819 . . . . 0.0 111.502 -179.926 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.74 -62.41 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.89 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -160.86 7.23 0.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.264 1.03 . . . . 0.0 111.711 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -74.04 -44.43 54.33 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 113.57 -1.65 . . . . 0.0 112.137 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.79 33.19 4.53 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 124.697 1.248 . . . . 0.0 110.908 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -137.99 -54.32 0.65 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 104.27 -2.492 . . . . 0.0 104.27 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -104.21 26.29 9.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 124.345 1.028 . . . . 0.0 109.595 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.6 m 47.37 38.72 7.83 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 113.991 -1.459 . . . . 0.0 111.15 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.13 -7.31 76.63 Favored Glycine 0 N--CA 1.497 2.72 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.219 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -59.32 175.24 0.33 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 124.289 0.641 . . . . 0.0 112.094 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -118.87 135.43 54.56 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.441 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.428 ' CG1' ' H ' ' A' ' 14' ' ' HIS . 2.6 t -138.03 -54.21 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-N 113.593 -1.64 . . . . 0.0 111.61 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.3 m170 78.76 -5.08 2.07 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 125.05 1.469 . . . . 0.0 112.933 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.428 ' H ' ' CG1' ' A' ' 12' ' ' VAL . 22.8 m-70 -98.26 -98.65 0.21 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -60.08 -19.35 52.76 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.426 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 27.7 tt0 -47.66 -52.44 18.15 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.553 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 pp -79.48 -18.93 50.96 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.352 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.6 t -71.05 -19.87 21.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.426 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 15.8 m-85 -76.06 -23.13 55.05 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -83.09 -49.93 9.02 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.1 -34.13 73.06 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -58.76 -41.81 87.45 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 113.886 -1.506 . . . . 0.0 110.064 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.72 -48.96 43.59 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.878 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.7 t -51.05 -52.71 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 124.411 1.07 . . . . 0.0 110.376 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 145.43 -133.15 4.93 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.1 m -147.84 46.8 1.1 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 61.08 9.22 2.28 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.949 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt . . . . . 0 N--CA 1.5 2.056 0 CA-C-O 117.582 -1.199 . . . . 0.0 112.397 -179.891 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.485 0.66 . . . . 0.0 109.26 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.59 55.97 3.84 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 122.299 1.047 . . . . 0.0 108.806 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.43 74.0 9.43 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 124.993 2.33 . . . . 0.0 110.824 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.425 ' C ' ' H ' ' A' ' 6' ' ' HIS . 4.5 m-85 -158.26 -26.92 0.08 Allowed 'General case' 0 N--CA 1.495 1.784 1 CA-C-N 108.032 -4.167 . . . . 0.0 107.081 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -89.9 27.25 1.61 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.992 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.425 ' H ' ' C ' ' A' ' 4' ' ' PHE . 19.4 m80 68.32 53.96 0.57 Allowed 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 100.214 -3.995 . . . . 0.0 100.214 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.7 t70 60.87 56.13 2.98 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 111.36 -2.655 . . . . 0.0 111.579 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 65.02 28.91 12.39 Favored 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.425 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 72.4 61.03 3.8 Favored Glycine 0 N--CA 1.494 2.55 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.242 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -64.41 -168.71 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.442 0.639 . . . . 0.0 112.568 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.92 100.51 8.1 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 42.8 t -55.32 -66.95 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 112.321 -2.218 . . . . 0.0 111.998 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 58.29 7.07 0.61 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 124.099 0.874 . . . . 0.0 112.704 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -87.7 -76.19 0.39 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -85.77 -24.87 26.69 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 113.566 -1.652 . . . . 0.0 107.725 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.424 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 25.8 tt0 -46.25 -50.36 16.06 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 114.217 -1.356 . . . . 0.0 110.605 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.41 -22.18 48.16 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.274 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.4 t -70.61 -19.67 21.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.424 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 14.3 m-30 -75.08 -24.03 58.09 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.83 -49.2 9.94 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.45 -33.39 69.67 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -61.47 -40.26 93.89 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.921 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.92 -48.59 57.94 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 124.567 1.167 . . . . 0.0 108.907 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 44.5 t -52.62 -53.2 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 124.652 1.22 . . . . 0.0 110.553 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 173.48 37.9 0.04 OUTLIER Glycine 0 N--CA 1.496 2.652 0 C-N-CA 119.898 -1.144 . . . . 0.0 112.942 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 78.3 p 42.52 27.67 0.1 Allowed 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -151.25 -70.12 0.17 Allowed 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 116.923 -1.513 . . . . 0.0 108.826 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 22.7 t70 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.99 -73.36 0.19 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -172.49 21.32 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.465 ' C ' ' H ' ' A' ' 6' ' ' HIS . 9.2 p90 -104.96 -44.34 4.83 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.251 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.5 ttp85 -70.17 2.91 3.19 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 122.833 1.301 . . . . 0.0 113.176 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.465 ' H ' ' C ' ' A' ' 4' ' ' PHE . 17.2 m170 -76.12 -46.06 30.63 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 112.598 -2.092 . . . . 0.0 109.416 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -176.33 25.8 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 O-C-N 124.274 0.984 . . . . 0.0 112.009 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.9 t -161.59 45.68 0.17 Allowed 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.683 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.07 -41.62 0.05 OUTLIER Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -153.54 -166.46 2.41 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.454 ' C ' ' H ' ' A' ' 13' ' ' HIS . 0.9 OUTLIER -158.29 21.25 0.24 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 123.603 0.564 . . . . 0.0 112.057 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.0 t 72.49 -34.66 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 125.747 1.905 . . . . 0.0 112.027 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.454 ' H ' ' C ' ' A' ' 11' ' ' GLU . 6.5 m170 74.86 38.07 0.48 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -137.56 -79.54 0.37 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 112.909 -1.95 . . . . 0.0 107.231 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -51.77 -47.74 64.04 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.406 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.48 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 27.7 tt0 -49.64 -34.74 19.08 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.106 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 mt -81.41 -28.35 34.35 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 114.847 -1.069 . . . . 0.0 111.723 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.4 t -65.68 -26.92 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 C-N-CA 118.475 -1.29 . . . . 0.0 107.577 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.48 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 4.7 m-30 -71.37 -26.98 63.02 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 113.76 -1.564 . . . . 0.0 107.672 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -78.97 -47.99 15.31 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.86 -26.92 69.0 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -72.52 -22.7 60.99 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 118.714 -1.194 . . . . 0.0 111.763 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -99.22 -44.02 6.4 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 124.055 0.847 . . . . 0.0 113.193 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.9 t -102.72 -28.41 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 123.954 0.784 . . . . 0.0 112.24 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 41.23 61.19 2.11 Favored Glycine 0 N--CA 1.504 3.204 0 O-C-N 123.974 0.796 . . . . 0.0 113.142 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.9 p -149.07 -84.1 0.1 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 123.954 0.443 . . . . 0.0 110.607 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -81.69 -1.98 48.82 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 123.692 0.62 . . . . 0.0 111.055 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.503 2.215 0 CA-C-O 115.305 -2.283 . . . . 0.0 114.068 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.496 1.86 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 41.29 34.68 0.35 Allowed 'General case' 0 N--CA 1.509 2.517 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 48.04 18.84 0.16 Allowed 'General case' 0 N--CA 1.502 2.131 0 CA-C-N 114.603 -1.181 . . . . 0.0 114.093 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -65.91 -36.42 83.35 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.22 20.12 4.6 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 113.967 -1.469 . . . . 0.0 111.122 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -119.02 -51.87 2.33 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.431 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -130.67 35.12 4.04 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.2 p -176.68 34.4 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.234 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.492 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.47 76.72 0.03 OUTLIER Glycine 0 N--CA 1.494 2.534 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.466 ' CG ' ' N ' ' A' ' 11' ' ' GLU . 6.3 p90 -43.42 -40.78 3.92 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 121.339 0.59 . . . . 0.0 112.216 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.466 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 20.2 mt-10 39.11 106.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 126.043 2.089 . . . . 0.0 116.311 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.3 t -126.93 -63.77 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-N 112.94 -1.936 . . . . 0.0 106.328 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.406 ' CD2' ' N ' ' A' ' 13' ' ' HIS . 12.1 m170 82.11 7.66 0.95 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 125.958 2.036 . . . . 0.0 112.024 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 -104.68 -78.16 0.57 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 103.7 -2.704 . . . . 0.0 103.7 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -63.66 -17.67 63.17 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.658 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.62 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 32.0 tt0 -60.95 -48.59 81.1 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.596 -1.183 . . . . 0.0 110.621 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.04 -19.51 61.83 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.203 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.6 t -76.36 -41.79 36.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.868 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.62 ' CE2' ' HA ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -78.6 -19.79 51.95 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 125.28 1.613 . . . . 0.0 108.747 -179.595 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -79.91 -41.62 25.76 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.38 -33.67 74.68 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.77 -27.56 64.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 124.938 1.399 . . . . 0.0 108.826 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -78.25 -54.33 6.34 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.894 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.1 t -78.16 -3.98 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 123.722 0.639 . . . . 0.0 110.466 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.02 74.45 0.34 Allowed Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.8 p 48.78 34.92 5.68 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 125.019 1.07 . . . . 0.0 111.124 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 58.14 61.52 2.3 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.494 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 116.779 -1.582 . . . . 0.0 110.444 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 120.714 0.292 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.72 -24.36 19.49 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.504 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.428 ' C ' ' H ' ' A' ' 5' ' ' ARG . 0.7 OUTLIER 32.73 32.31 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 117.241 2.311 . . . . 0.0 117.241 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.465 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -74.35 14.19 0.48 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 113.11 -1.859 . . . . 0.0 110.277 179.563 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.428 ' H ' ' C ' ' A' ' 3' ' ' GLU . 10.0 mtm-85 55.81 27.56 11.06 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 122.75 1.262 . . . . 0.0 108.406 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.447 ' O ' ' CB ' ' A' ' 7' ' ' ASP . 17.4 m-70 52.88 17.08 0.8 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 111.213 -2.721 . . . . 0.0 111.093 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.447 ' CB ' ' O ' ' A' ' 6' ' ' HIS . 40.6 p-10 127.98 37.67 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.523 0 O-C-N 126.51 2.381 . . . . 0.0 111.647 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 p 59.59 32.8 21.8 Favored 'General case' 0 N--CA 1.506 2.372 0 CA-C-O 122.325 1.059 . . . . 0.0 110.916 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.12 68.7 0.15 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 105.473 -3.051 . . . . 0.0 105.473 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.71 167.19 7.69 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 114.079 1.141 . . . . 0.0 114.079 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.04 138.3 42.04 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 113.288 -1.778 . . . . 0.0 109.03 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 42.5 t -153.86 -60.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.473 ' N ' ' CD2' ' A' ' 13' ' ' HIS . 8.3 m170 74.87 -18.28 0.44 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 125.748 1.905 . . . . 0.0 113.166 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -57.31 -43.28 83.14 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.506 0.669 . . . . 0.0 109.392 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.1 -30.61 2.42 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 113.242 -1.799 . . . . 0.0 106.661 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.409 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 42.6 tt0 -50.32 -48.23 55.43 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.191 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.26 -20.45 48.1 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.469 -1.292 . . . . 0.0 110.738 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.5 t -70.49 -19.34 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.409 ' CE2' ' HA ' ' A' ' 16' ' ' GLU . 16.9 m-30 -72.41 -25.02 61.32 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -82.15 -48.2 11.6 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.07 -25.35 65.32 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.19 -38.47 60.8 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 125.331 1.644 . . . . 0.0 108.35 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.08 -48.04 75.16 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.5 t -70.02 -17.7 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.382 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.69 52.77 48.54 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.1 t 53.13 30.39 9.67 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 124.564 0.803 . . . . 0.0 111.19 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 72.61 56.12 0.14 Allowed 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.713 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.985 0 CA-C-N 113.268 -1.787 . . . . 0.0 107.881 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 120.918 0.389 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.11 -24.53 67.45 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.661 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 63.92 101.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 124.558 1.161 . . . . 0.0 110.513 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -163.89 -38.92 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 114.207 -1.36 . . . . 0.0 109.992 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -74.97 -9.8 58.88 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-O 122.602 1.191 . . . . 0.0 110.397 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -61.48 -22.93 65.53 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 111.686 -2.506 . . . . 0.0 109.164 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -141.09 19.92 2.28 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 114.616 -1.174 . . . . 0.0 109.729 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.4 t 47.37 44.5 16.35 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 114.126 -1.397 . . . . 0.0 111.659 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.39 55.18 0.3 Allowed Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.17 -179.78 0.12 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.95 162.62 29.28 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.288 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.0 t -143.55 -54.46 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.592 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 78.64 24.66 0.57 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 126.231 2.207 . . . . 0.0 112.346 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -119.3 -94.07 0.51 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 101.726 -3.435 . . . . 0.0 101.726 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -62.74 -20.9 65.39 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -47.93 -52.18 20.56 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.896 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.65 -16.68 55.32 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.766 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.9 t -72.19 -21.38 20.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -75.95 -23.95 55.44 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -80.74 -47.7 13.58 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.34 -40.18 81.46 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.64 -36.99 80.03 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 113.489 -1.687 . . . . 0.0 109.828 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.05 -49.38 65.33 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.55 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.7 t -54.31 -53.98 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 124.42 1.075 . . . . 0.0 109.526 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.96 -35.9 2.53 Favored Glycine 0 N--CA 1.496 2.672 0 O-C-N 124.053 0.846 . . . . 0.0 112.807 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.0 m -57.59 -31.71 66.46 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.107 0.479 . . . . 0.0 111.181 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -107.37 -7.09 16.78 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.103 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.826 0 O-C-N 124.505 1.128 . . . . 0.0 109.355 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.58 -27.43 13.41 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 124.079 0.862 . . . . 0.0 111.141 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 36.19 32.29 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.44 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -75.96 24.91 0.12 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 113.684 -1.598 . . . . 0.0 112.944 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.6 mtp85 56.34 28.59 13.69 Favored 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.7 m170 56.26 53.97 8.26 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 112.789 -2.005 . . . . 0.0 106.49 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 64.43 36.7 8.71 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 113.318 -1.764 . . . . 0.0 111.19 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.7 m 62.53 64.82 0.89 Allowed 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 114.073 -1.421 . . . . 0.0 112.601 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.4 -83.06 0.16 Allowed Glycine 0 N--CA 1.484 1.888 1 N-CA-C 102.117 -4.393 . . . . 0.0 102.117 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -174.97 156.27 2.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 124.763 0.92 . . . . 0.0 109.899 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -134.04 109.14 8.77 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 122.206 1.003 . . . . 0.0 110.603 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.7 t -129.14 -60.69 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-N 112.384 -2.189 . . . . 0.0 106.323 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.444 ' N ' ' CD2' ' A' ' 13' ' ' HIS . 6.8 m170 75.66 0.19 3.34 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 125.48 1.738 . . . . 0.0 111.943 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -93.81 -88.95 0.22 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -56.39 -27.05 55.13 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.441 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 24.4 tt0 -48.84 -48.03 42.11 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 114.072 -1.422 . . . . 0.0 109.151 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.51 -20.81 46.32 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 124.169 0.918 . . . . 0.0 111.858 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.7 t -70.27 -21.98 23.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.441 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 11.5 m-30 -74.39 -23.16 58.93 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -81.82 -44.19 17.26 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.35 -38.74 81.16 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -59.89 -36.9 77.93 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.525 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.59 -50.32 52.55 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.8 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.4 t -53.0 -56.54 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 124.55 1.157 . . . . 0.0 109.507 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.45 -1.24 0.3 Allowed Glycine 0 N--CA 1.499 2.839 0 O-C-N 124.073 0.858 . . . . 0.0 115.221 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.7 m -75.63 -93.96 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -66.57 -18.97 65.66 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.6 mmtt . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 116.466 -1.731 . . . . 0.0 108.89 179.87 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.508 0.67 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.64 -16.77 63.44 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.151 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 54.81 18.09 2.01 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 124.686 1.241 . . . . 0.0 113.879 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.407 ' C ' ' H ' ' A' ' 6' ' ' HIS . 41.3 t80 -52.69 -58.6 6.3 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.06 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.47 10.07 0.1 Allowed 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 116.792 2.145 . . . . 0.0 116.792 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.407 ' H ' ' C ' ' A' ' 4' ' ' PHE . 23.6 m170 -92.37 -19.88 21.63 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -152.19 19.11 0.66 Allowed 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 114.418 -1.265 . . . . 0.0 108.827 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.0 t 53.03 25.1 3.84 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 121.874 0.845 . . . . 0.0 109.865 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 55.53 34.07 59.71 Favored Glycine 0 N--CA 1.497 2.702 0 CA-C-N 113.898 -1.501 . . . . 0.0 112.147 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.73 148.57 24.68 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 120.896 0.379 . . . . 0.0 110.921 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -141.49 128.82 21.13 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 t -131.33 -62.23 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.067 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.406 ' CD2' ' N ' ' A' ' 13' ' ' HIS . 7.4 m170 77.3 -22.72 0.27 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 125.328 1.643 . . . . 0.0 110.795 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 29.7 m-70 -75.17 -95.9 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.37 -27.23 62.11 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.473 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 29.2 tt0 -49.98 -46.15 52.26 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 113.889 -1.505 . . . . 0.0 108.955 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.52 -23.38 46.31 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.27 -0.972 . . . . 0.0 111.145 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.0 t -70.9 -17.15 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.473 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 15.0 m-30 -75.98 -15.6 60.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 124.437 1.085 . . . . 0.0 108.135 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -96.9 -48.53 5.4 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.39 -16.52 55.23 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 114.038 -1.437 . . . . 0.0 107.403 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.46 -45.89 78.23 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -65.52 -48.07 73.78 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 114.007 -1.451 . . . . 0.0 107.969 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.5 t -59.23 -21.65 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.583 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.24 48.02 55.1 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 46.4 p 47.09 27.74 0.82 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 124.945 1.027 . . . . 0.0 112.828 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 54.28 62.38 2.6 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 114.757 -1.111 . . . . 0.0 110.884 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.9 mtpp . . . . . 0 N--CA 1.499 2.019 0 CA-C-O 116.311 -1.804 . . . . 0.0 111.169 179.935 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.49 -107.85 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -168.75 27.27 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 121.792 0.806 . . . . 0.0 109.429 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.416 ' C ' ' H ' ' A' ' 6' ' ' HIS . 9.6 m-85 -56.2 -63.55 1.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.35 -1.296 . . . . 0.0 111.12 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.88 17.8 0.3 Allowed 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.416 ' H ' ' C ' ' A' ' 4' ' ' PHE . 8.0 m-70 -107.39 -56.19 2.24 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 114.313 -1.312 . . . . 0.0 107.817 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -165.08 35.82 0.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.946 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.5 t -158.56 32.17 0.23 Allowed 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 121.332 0.587 . . . . 0.0 111.631 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 177.15 -30.9 0.08 OUTLIER Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -63.61 175.77 1.01 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.809 0.814 . . . . 0.0 112.42 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -153.15 148.76 27.31 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 t -139.16 -50.59 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 124.042 0.839 . . . . 0.0 110.917 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.9 m170 73.73 -7.35 1.6 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 124.583 1.177 . . . . 0.0 112.651 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 -95.46 -97.63 0.17 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 103.468 -2.79 . . . . 0.0 103.468 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -55.83 -23.48 30.72 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.469 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 34.4 tt0 -48.29 -44.0 33.32 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 114.063 -1.426 . . . . 0.0 110.978 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.46 -24.39 27.44 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.632 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.6 t -69.4 -16.65 20.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.469 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 19.3 m-30 -75.31 -22.9 57.34 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -83.94 -48.13 10.3 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.3 -27.56 68.57 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -63.15 -42.37 99.45 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.474 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.77 -47.84 73.84 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.639 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 82.6 t -51.74 -52.32 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 124.688 1.243 . . . . 0.0 109.427 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.82 25.93 1.47 Allowed Glycine 0 N--CA 1.496 2.661 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.8 m 42.09 22.83 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 50.59 29.47 4.11 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.419 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 116.129 -1.891 . . . . 0.0 111.526 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.37 -24.14 4.0 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.517 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 38.76 31.61 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 125.448 1.717 . . . . 0.0 112.587 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -121.32 79.29 1.51 Allowed 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 113.073 -1.876 . . . . 0.0 106.182 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 91.6 56.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 111.148 -2.751 . . . . 0.0 106.112 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 58.0 46.32 16.63 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 112.225 -2.261 . . . . 0.0 107.065 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.5 t0 76.68 38.02 0.29 Allowed 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 113.355 -1.748 . . . . 0.0 110.212 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.431 ' HG ' ' HH ' ' A' ' 10' ' ' TYR . 66.1 m 64.63 75.73 0.36 Allowed 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 122.872 1.32 . . . . 0.0 110.256 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.35 -16.72 78.75 Favored Glycine 0 N--CA 1.491 2.313 0 CA-C-N 112.04 -2.345 . . . . 0.0 109.667 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.431 ' HH ' ' HG ' ' A' ' 8' ' ' SER . 43.9 p90 -74.51 168.76 19.1 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 124.169 0.57 . . . . 0.0 111.009 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.23 26.36 0.1 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 118.045 2.609 . . . . 0.0 118.045 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.0 t 72.59 -58.27 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 125.525 1.766 . . . . 0.0 112.268 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 11.9 m170 90.41 -5.42 0.31 Allowed 'General case' 0 N--CA 1.505 2.281 0 O-C-N 126.336 2.273 . . . . 0.0 113.574 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.49 ' N ' ' CD2' ' A' ' 14' ' ' HIS . 0.0 OUTLIER -124.77 -65.86 1.01 Allowed 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.702 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -54.37 -27.5 36.84 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.621 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.597 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 25.9 tt0 -64.29 -45.08 89.55 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.053 -1.059 . . . . 0.0 109.456 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.6 -20.95 62.71 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.832 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.9 t -75.14 -45.9 40.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.694 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.597 ' CE2' ' HA ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -76.25 -19.05 58.69 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.228 -1.351 . . . . 0.0 108.959 -179.621 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -80.52 -39.43 27.86 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.4 -42.7 95.96 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.64 -35.39 76.07 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 113.628 -1.624 . . . . 0.0 109.524 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.16 -51.72 50.24 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.512 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.5 t -51.74 -50.22 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 124.129 0.893 . . . . 0.0 109.784 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.17 41.02 9.67 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.0 p -131.12 -34.5 1.44 Allowed 'General case' 0 N--CA 1.499 1.975 0 CA-C-N 114.22 -0.99 . . . . 0.0 109.203 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.43 ' H ' ' ND2' ' A' ' 27' ' ' ASN . 0.0 OUTLIER -113.71 -17.46 12.1 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 113.315 -1.766 . . . . 0.0 108.571 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp . . . . . 0 N--CA 1.498 1.942 0 CA-C-O 114.788 -2.529 . . . . 0.0 110.96 179.94 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.9 t0 . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.83 -16.72 64.08 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.772 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 54.95 23.12 4.79 Favored 'General case' 0 N--CA 1.504 2.244 0 CA-C-O 122.69 1.233 . . . . 0.0 112.298 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.551 ' H ' ' NH2' ' A' ' 5' ' ' ARG . 20.6 t80 -53.43 -39.01 64.05 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 112.474 -2.148 . . . . 0.0 110.913 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.551 ' NH2' ' H ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -76.77 17.55 0.41 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 123.877 0.735 . . . . 0.0 112.887 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.437 ' H ' ' C ' ' A' ' 4' ' ' PHE . 11.2 m80 -131.16 -58.69 1.0 Allowed 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.785 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -85.19 9.27 15.55 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.345 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.0 t -170.53 24.69 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 113.361 -1.745 . . . . 0.0 108.811 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.55 -42.46 6.49 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -56.34 151.48 12.87 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 114.357 -0.921 . . . . 0.0 110.884 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -76.77 138.91 40.19 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 124.254 0.971 . . . . 0.0 110.497 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.4 t -127.18 -56.68 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 113.219 -1.809 . . . . 0.0 107.569 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 12.0 m170 89.41 -2.25 0.36 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 126.852 2.595 . . . . 0.0 110.524 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 -100.9 -98.21 0.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 103.549 -2.76 . . . . 0.0 103.549 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -53.87 -25.2 18.7 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.446 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 29.1 tt0 -46.73 -47.71 20.55 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.139 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.98 -24.45 32.93 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.296 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.9 t -68.88 -18.7 23.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.446 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 17.9 m-85 -74.83 -23.65 58.48 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -84.71 -48.39 9.49 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.56 -34.58 71.21 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -57.6 -42.58 83.51 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.075 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.68 -51.9 50.88 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.392 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.3 t -51.78 -51.61 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 124.726 1.266 . . . . 0.0 111.038 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -38.22 101.23 0.01 OUTLIER Glycine 0 N--CA 1.498 2.786 0 O-C-N 124.337 1.023 . . . . 0.0 113.583 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.8 t 40.23 36.51 0.33 Allowed 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 114.394 -0.903 . . . . 0.0 113.331 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.9 p30 40.64 31.62 0.12 Allowed 'General case' 0 N--CA 1.504 2.248 0 O-C-N 124.354 1.034 . . . . 0.0 113.659 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt . . . . . 0 N--CA 1.502 2.126 0 CA-C-O 117.936 -1.031 . . . . 0.0 113.109 -179.883 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 24.7 p90 . . . . . 0 N--CA 1.504 2.241 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -164.26 7.81 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.029 0.443 . . . . 0.0 111.325 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.0 t 69.61 -42.48 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 126.011 2.07 . . . . 0.0 114.694 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.3 m80 75.48 40.17 0.32 Allowed 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -139.07 -28.3 0.79 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 112.963 -1.926 . . . . 0.0 110.697 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -117.92 -41.28 2.91 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 124.579 1.174 . . . . 0.0 110.956 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.565 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 27.5 tt0 -59.13 -40.41 85.36 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 117.312 -1.755 . . . . 0.0 111.208 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.92 -15.25 61.58 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.627 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.7 t -76.29 -47.72 29.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.478 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.565 ' CE2' ' HA ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -72.49 -28.23 62.76 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 113.112 -1.858 . . . . 0.0 107.565 -179.499 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -72.22 -40.43 67.79 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.6 -45.97 87.95 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -65.28 -25.15 67.52 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 124.746 1.279 . . . . 0.0 111.151 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.57 -50.03 48.61 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.7 t -59.89 -47.6 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 159.76 -55.41 0.34 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 104.016 -3.634 . . . . 0.0 104.016 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.8 m -170.11 36.47 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.5 t30 55.71 30.37 15.46 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 114.252 -1.34 . . . . 0.0 110.689 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm . . . . . 0 N--CA 1.504 2.274 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.662 -179.816 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 13.3 p90 . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -83.8 117.85 23.55 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 113.67 -1.604 . . . . 0.0 109.993 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.539 HG12 ' H ' ' A' ' 14' ' ' HIS . 48.7 t -91.83 -55.69 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-N 112.283 -2.235 . . . . 0.0 112.383 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.48 ' H ' ' HB3' ' A' ' 16' ' ' GLU . 17.9 m-70 76.23 -2.5 2.72 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 125.355 1.659 . . . . 0.0 112.548 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.539 ' H ' HG12 ' A' ' 12' ' ' VAL . 12.1 m-70 -77.33 -50.37 12.96 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.794 0.807 . . . . 0.0 109.787 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -124.82 -31.03 3.21 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 112.695 -2.048 . . . . 0.0 108.454 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.48 ' HB3' ' H ' ' A' ' 13' ' ' HIS . 10.4 tt0 -46.01 -51.25 13.91 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 124.803 1.314 . . . . 0.0 110.493 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.483 HD12 ' C ' ' A' ' 17' ' ' LEU . 4.4 pp -82.69 -15.21 52.83 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 117.701 -1.6 . . . . 0.0 112.75 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.5 t -72.59 -18.9 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -75.21 -14.01 60.5 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.944 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.533 ' CZ ' HG21 ' A' ' 24' ' ' VAL . 1.5 t80 -103.03 -49.43 3.76 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.8 -15.06 57.8 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 113.992 -1.458 . . . . 0.0 107.122 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.42 -48.65 69.33 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -70.27 -59.28 2.97 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 113.449 -1.705 . . . . 0.0 112.369 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.533 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 2.5 t -59.68 -38.79 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.056 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.98 -51.92 54.37 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.0 t -55.39 -49.09 73.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 124.524 0.779 . . . . 0.0 109.918 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -50.91 -56.09 14.0 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 124.635 1.209 . . . . 0.0 110.015 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.4 ' HE3' HG12 ' A' ' 24' ' ' VAL . 15.2 mttp . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 116.59 -1.671 . . . . 0.0 110.436 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.413 ' CG ' ' N ' ' A' ' 11' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 122.029 0.919 . . . . 0.0 110.081 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.413 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -172.44 141.72 1.21 Allowed 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 112.917 -1.947 . . . . 0.0 105.877 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.713 HG12 ' H ' ' A' ' 14' ' ' HIS . 3.5 t -143.01 -59.75 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.915 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.3 m80 65.31 -2.13 0.83 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 124.425 1.078 . . . . 0.0 112.299 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.713 ' H ' HG12 ' A' ' 12' ' ' VAL . 9.5 m-70 -89.6 -97.76 0.1 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 103.123 -2.917 . . . . 0.0 103.123 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.74 -28.5 65.92 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.46 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 34.0 tt0 -45.1 -48.94 11.99 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 113.545 -1.661 . . . . 0.0 112.477 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mt -86.35 -23.52 26.18 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.936 0.874 . . . . 0.0 109.551 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 14' ' ' HIS . 52.6 t -69.23 -15.45 19.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.46 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 22.7 m-85 -74.61 -22.98 58.66 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -86.01 -45.26 11.62 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 104.697 -2.334 . . . . 0.0 104.697 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.74 -31.41 68.29 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -65.28 -40.62 94.12 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 114.175 -1.375 . . . . 0.0 109.209 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.16 -49.27 74.99 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.096 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.1 t -53.28 -54.09 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 124.692 1.245 . . . . 0.0 108.609 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 157.12 -57.9 0.37 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 106.551 -2.62 . . . . 0.0 106.551 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.0 t -167.77 47.91 0.05 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.1 17.01 7.64 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.246 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 116.281 -1.819 . . . . 0.0 111.502 -179.926 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.9 p90 . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -118.87 135.43 54.56 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.441 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.936 HG12 ' H ' ' A' ' 14' ' ' HIS . 2.6 t -138.03 -54.21 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-N 113.593 -1.64 . . . . 0.0 111.61 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.3 m170 78.76 -5.08 2.07 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 125.05 1.469 . . . . 0.0 112.933 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.936 ' H ' HG12 ' A' ' 12' ' ' VAL . 22.8 m-70 -98.26 -98.65 0.21 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -60.08 -19.35 52.76 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.445 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 27.7 tt0 -47.66 -52.44 18.15 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.553 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 pp -79.48 -18.93 50.96 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.352 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.6 t -71.05 -19.87 21.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.445 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 15.8 m-85 -76.06 -23.13 55.05 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -83.09 -49.93 9.02 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.1 -34.13 73.06 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -58.76 -41.81 87.45 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 113.886 -1.506 . . . . 0.0 110.064 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.72 -48.96 43.59 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.878 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.7 t -51.05 -52.71 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 124.411 1.07 . . . . 0.0 110.376 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 145.43 -133.15 4.93 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.1 m -147.84 46.8 1.1 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 61.08 9.22 2.28 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.949 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt . . . . . 0 N--CA 1.5 2.056 0 CA-C-O 117.582 -1.199 . . . . 0.0 112.397 -179.891 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 121.442 0.639 . . . . 0.0 112.568 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.92 100.51 8.1 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.766 HG12 ' H ' ' A' ' 14' ' ' HIS . 42.8 t -55.32 -66.95 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 112.321 -2.218 . . . . 0.0 111.998 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 20.3 m80 58.29 7.07 0.61 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 124.099 0.874 . . . . 0.0 112.704 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.766 ' H ' HG12 ' A' ' 12' ' ' VAL . 3.3 m-70 -87.7 -76.19 0.39 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -85.77 -24.87 26.69 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 113.566 -1.652 . . . . 0.0 107.725 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.453 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 25.8 tt0 -46.25 -50.36 16.06 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 114.217 -1.356 . . . . 0.0 110.605 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.41 ' H ' ' HG ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -78.41 -22.18 48.16 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.274 -179.889 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.4 t -70.61 -19.67 21.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.453 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 14.3 m-30 -75.08 -24.03 58.09 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.83 -49.2 9.94 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.45 -33.39 69.67 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -61.47 -40.26 93.89 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.921 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.92 -48.59 57.94 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 124.567 1.167 . . . . 0.0 108.907 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 44.5 t -52.62 -53.2 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 124.652 1.22 . . . . 0.0 110.553 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 173.48 37.9 0.04 OUTLIER Glycine 0 N--CA 1.496 2.652 0 C-N-CA 119.898 -1.144 . . . . 0.0 112.942 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 78.3 p 42.52 27.67 0.1 Allowed 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -151.25 -70.12 0.17 Allowed 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 116.923 -1.513 . . . . 0.0 108.826 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.448 ' C ' ' H ' ' A' ' 13' ' ' HIS . 0.9 OUTLIER -158.29 21.25 0.24 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 123.603 0.564 . . . . 0.0 112.057 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.0 t 72.49 -34.66 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 125.747 1.905 . . . . 0.0 112.027 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.448 ' H ' ' C ' ' A' ' 11' ' ' GLU . 0.8 OUTLIER 74.86 38.07 0.48 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -137.56 -79.54 0.37 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 112.909 -1.95 . . . . 0.0 107.231 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -51.77 -47.74 64.04 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.406 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.504 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 27.7 tt0 -49.64 -34.74 19.08 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.106 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 mt -81.41 -28.35 34.35 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 114.847 -1.069 . . . . 0.0 111.723 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.4 t -65.68 -26.92 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 C-N-CA 118.475 -1.29 . . . . 0.0 107.577 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.504 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 4.7 m-30 -71.37 -26.98 63.02 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 113.76 -1.564 . . . . 0.0 107.672 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -78.97 -47.99 15.31 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.86 -26.92 69.0 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -72.52 -22.7 60.99 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 118.714 -1.194 . . . . 0.0 111.763 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -99.22 -44.02 6.4 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 124.055 0.847 . . . . 0.0 113.193 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.9 t -102.72 -28.41 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 123.954 0.784 . . . . 0.0 112.24 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 41.23 61.19 2.11 Favored Glycine 0 N--CA 1.504 3.204 0 O-C-N 123.974 0.796 . . . . 0.0 113.142 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.9 p -149.07 -84.1 0.1 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 123.954 0.443 . . . . 0.0 110.607 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -81.69 -1.98 48.82 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 123.692 0.62 . . . . 0.0 111.055 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.415 ' HZ3' ' HB2' ' A' ' 28' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.503 2.215 0 CA-C-O 115.305 -2.283 . . . . 0.0 114.068 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.466 ' CG ' ' N ' ' A' ' 11' ' ' GLU . 6.3 p90 . . . . . 0 N--CA 1.503 2.207 0 CA-C-O 121.339 0.59 . . . . 0.0 112.216 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.466 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 20.2 mt-10 39.11 106.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 126.043 2.089 . . . . 0.0 116.311 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.859 HG12 ' H ' ' A' ' 14' ' ' HIS . 44.3 t -126.93 -63.77 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-N 112.94 -1.936 . . . . 0.0 106.328 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.406 ' CD2' ' N ' ' A' ' 13' ' ' HIS . 12.1 m170 82.11 7.66 0.95 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 125.958 2.036 . . . . 0.0 112.024 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.859 ' H ' HG12 ' A' ' 12' ' ' VAL . 21.6 m-70 -104.68 -78.16 0.57 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 103.7 -2.704 . . . . 0.0 103.7 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -63.66 -17.67 63.17 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.658 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.641 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 32.0 tt0 -60.95 -48.59 81.1 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.596 -1.183 . . . . 0.0 110.621 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.04 -19.51 61.83 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.203 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.6 t -76.36 -41.79 36.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.868 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.641 ' CE2' ' HA ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -78.6 -19.79 51.95 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 125.28 1.613 . . . . 0.0 108.747 -179.595 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -79.91 -41.62 25.76 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.38 -33.67 74.68 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.407 ' HB3' ' HA ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -70.77 -27.56 64.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 124.938 1.399 . . . . 0.0 108.826 179.681 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -78.25 -54.33 6.34 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.894 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.1 t -78.16 -3.98 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 123.722 0.639 . . . . 0.0 110.466 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.02 74.45 0.34 Allowed Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.8 p 48.78 34.92 5.68 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 125.019 1.07 . . . . 0.0 111.124 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 58.14 61.52 2.3 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.494 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 116.779 -1.582 . . . . 0.0 110.444 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 114.079 1.141 . . . . 0.0 114.079 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.04 138.3 42.04 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 113.288 -1.778 . . . . 0.0 109.03 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.644 HG12 ' H ' ' A' ' 14' ' ' HIS . 42.5 t -153.86 -60.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.55 ' H ' ' HB3' ' A' ' 16' ' ' GLU . 1.8 m-70 74.87 -18.28 0.44 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 125.748 1.905 . . . . 0.0 113.166 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.644 ' H ' HG12 ' A' ' 12' ' ' VAL . 11.6 m-70 -57.31 -43.28 83.14 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.506 0.669 . . . . 0.0 109.392 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.1 -30.61 2.42 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 113.242 -1.799 . . . . 0.0 106.661 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.55 ' HB3' ' H ' ' A' ' 13' ' ' HIS . 42.6 tt0 -50.32 -48.23 55.43 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.191 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -79.26 -20.45 48.1 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.469 -1.292 . . . . 0.0 110.738 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.5 t -70.49 -19.34 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.413 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 16.9 m-30 -72.41 -25.02 61.32 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -82.15 -48.2 11.6 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.07 -25.35 65.32 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.19 -38.47 60.8 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 125.331 1.644 . . . . 0.0 108.35 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.08 -48.04 75.16 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.5 t -70.02 -17.7 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.382 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.69 52.77 48.54 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.1 t 53.13 30.39 9.67 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 124.564 0.803 . . . . 0.0 111.19 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 72.61 56.12 0.14 Allowed 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.713 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.985 0 CA-C-N 113.268 -1.787 . . . . 0.0 107.881 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.927 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.95 162.62 29.28 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.288 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.422 ' O ' ' HB2' ' A' ' 13' ' ' HIS . 74.0 t -143.55 -54.46 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.592 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.422 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 15.1 m-70 78.64 24.66 0.57 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 126.231 2.207 . . . . 0.0 112.346 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -119.3 -94.07 0.51 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 101.726 -3.435 . . . . 0.0 101.726 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -62.74 -20.9 65.39 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.416 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 30.3 tt0 -47.93 -52.18 20.56 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.896 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.65 -16.68 55.32 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.766 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.9 t -72.19 -21.38 20.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.416 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 12.8 m-85 -75.95 -23.95 55.44 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -80.74 -47.7 13.58 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.34 -40.18 81.46 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.64 -36.99 80.03 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 113.489 -1.687 . . . . 0.0 109.828 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.05 -49.38 65.33 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.55 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.7 t -54.31 -53.98 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 124.42 1.075 . . . . 0.0 109.526 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.96 -35.9 2.53 Favored Glycine 0 N--CA 1.496 2.672 0 O-C-N 124.053 0.846 . . . . 0.0 112.807 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.0 m -57.59 -31.71 66.46 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.107 0.479 . . . . 0.0 111.181 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -107.37 -7.09 16.78 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.103 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.826 0 O-C-N 124.505 1.128 . . . . 0.0 109.355 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.6 p90 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -134.04 109.14 8.77 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 122.206 1.003 . . . . 0.0 110.603 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.888 HG12 ' H ' ' A' ' 14' ' ' HIS . 41.7 t -129.14 -60.69 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-N 112.384 -2.189 . . . . 0.0 106.323 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 75.66 0.19 3.34 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 125.48 1.738 . . . . 0.0 111.943 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.888 ' H ' HG12 ' A' ' 12' ' ' VAL . 20.0 m-70 -93.81 -88.95 0.22 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -56.39 -27.05 55.13 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.455 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 24.4 tt0 -48.84 -48.03 42.11 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 114.072 -1.422 . . . . 0.0 109.151 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.51 -20.81 46.32 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 124.169 0.918 . . . . 0.0 111.858 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.7 t -70.27 -21.98 23.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.455 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 11.5 m-30 -74.39 -23.16 58.93 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -81.82 -44.19 17.26 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.35 -38.74 81.16 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -59.89 -36.9 77.93 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.525 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.59 -50.32 52.55 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.8 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.615 HG12 ' H ' ' A' ' 26' ' ' SER . 77.4 t -53.0 -56.54 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 124.55 1.157 . . . . 0.0 109.507 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.45 -1.24 0.3 Allowed Glycine 0 N--CA 1.499 2.839 0 O-C-N 124.073 0.858 . . . . 0.0 115.221 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.615 ' H ' HG12 ' A' ' 24' ' ' VAL . 47.7 m -75.63 -93.96 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -66.57 -18.97 65.66 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.6 mmtt . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 116.466 -1.731 . . . . 0.0 108.89 179.87 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 120.896 0.379 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -141.49 128.82 21.13 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.501 HG12 ' H ' ' A' ' 14' ' ' HIS . 6.0 t -131.33 -62.23 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.067 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.536 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.4 OUTLIER 77.3 -22.72 0.27 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 125.328 1.643 . . . . 0.0 110.795 -179.869 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.501 ' H ' HG12 ' A' ' 12' ' ' VAL . 29.7 m-70 -75.17 -95.9 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.37 -27.23 62.11 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.484 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 29.2 tt0 -49.98 -46.15 52.26 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 113.889 -1.505 . . . . 0.0 108.955 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.536 HD23 ' O ' ' A' ' 13' ' ' HIS . 0.5 OUTLIER -78.52 -23.38 46.31 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.27 -0.972 . . . . 0.0 111.145 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.437 ' HA ' ' HB3' ' A' ' 21' ' ' ALA . 61.0 t -70.9 -17.15 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.484 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 15.0 m-30 -75.98 -15.6 60.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 124.437 1.085 . . . . 0.0 108.135 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -96.9 -48.53 5.4 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 18' ' ' VAL . . . -62.39 -16.52 55.23 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 114.038 -1.437 . . . . 0.0 107.403 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.46 -45.89 78.23 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -65.52 -48.07 73.78 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 114.007 -1.451 . . . . 0.0 107.969 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.5 t -59.23 -21.65 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.583 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.24 48.02 55.1 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 46.4 p 47.09 27.74 0.82 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 124.945 1.027 . . . . 0.0 112.828 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.9 m120 54.28 62.38 2.6 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 114.757 -1.111 . . . . 0.0 110.884 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.9 mtpp . . . . . 0 N--CA 1.499 2.019 0 CA-C-O 116.311 -1.804 . . . . 0.0 111.169 179.935 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.809 0.814 . . . . 0.0 112.42 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -153.15 148.76 27.31 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.772 HG12 ' H ' ' A' ' 14' ' ' HIS . 2.4 t -139.16 -50.59 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 124.042 0.839 . . . . 0.0 110.917 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.9 m170 73.73 -7.35 1.6 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 124.583 1.177 . . . . 0.0 112.651 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.772 ' H ' HG12 ' A' ' 12' ' ' VAL . 20.7 m-70 -95.46 -97.63 0.17 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 103.468 -2.79 . . . . 0.0 103.468 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -55.83 -23.48 30.72 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.506 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 34.4 tt0 -48.29 -44.0 33.32 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 114.063 -1.426 . . . . 0.0 110.978 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.411 ' H ' ' HG ' ' A' ' 17' ' ' LEU . 1.0 OUTLIER -85.46 -24.39 27.44 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.632 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.6 t -69.4 -16.65 20.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.506 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 19.3 m-30 -75.31 -22.9 57.34 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -83.94 -48.13 10.3 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.3 -27.56 68.57 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -63.15 -42.37 99.45 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.474 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.77 -47.84 73.84 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.639 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 82.6 t -51.74 -52.32 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 124.688 1.243 . . . . 0.0 109.427 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.82 25.93 1.47 Allowed Glycine 0 N--CA 1.496 2.661 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.8 m 42.09 22.83 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 50.59 29.47 4.11 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.419 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 116.129 -1.891 . . . . 0.0 111.526 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 43.9 p90 . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 120.991 0.424 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.23 26.36 0.1 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 118.045 2.609 . . . . 0.0 118.045 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.697 HG12 ' CD2' ' A' ' 14' ' ' HIS . 45.0 t 72.59 -58.27 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 125.525 1.766 . . . . 0.0 112.268 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 11.9 m170 90.41 -5.42 0.31 Allowed 'General case' 0 N--CA 1.505 2.281 0 O-C-N 126.336 2.273 . . . . 0.0 113.574 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.697 ' CD2' HG12 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -124.77 -65.86 1.01 Allowed 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.702 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.597 ' HB2' HG11 ' A' ' 12' ' ' VAL . 1.9 mp0 -54.37 -27.5 36.84 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.621 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.631 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 25.9 tt0 -64.29 -45.08 89.55 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.053 -1.059 . . . . 0.0 109.456 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.6 -20.95 62.71 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.832 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.9 t -75.14 -45.9 40.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.694 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.631 ' CE2' ' HA ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -76.25 -19.05 58.69 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.228 -1.351 . . . . 0.0 108.959 -179.621 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.595 ' O ' HG23 ' A' ' 24' ' ' VAL . 84.8 t80 -80.52 -39.43 27.86 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.4 -42.7 95.96 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.64 -35.39 76.07 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 113.628 -1.624 . . . . 0.0 109.524 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.16 -51.72 50.24 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.512 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 20' ' ' PHE . 38.5 t -51.74 -50.22 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 124.129 0.893 . . . . 0.0 109.784 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.17 41.02 9.67 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.0 p -131.12 -34.5 1.44 Allowed 'General case' 0 N--CA 1.499 1.975 0 CA-C-N 114.22 -0.99 . . . . 0.0 109.203 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.71 -17.46 12.1 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 113.315 -1.766 . . . . 0.0 108.571 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp . . . . . 0 N--CA 1.498 1.942 0 CA-C-O 114.788 -2.529 . . . . 0.0 110.96 179.94 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.7 p90 . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 120.588 0.232 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -76.77 138.91 40.19 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 124.254 0.971 . . . . 0.0 110.497 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.454 HG12 ' H ' ' A' ' 14' ' ' HIS . 94.4 t -127.18 -56.68 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 113.219 -1.809 . . . . 0.0 107.569 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.43 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 12.0 m170 89.41 -2.25 0.36 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 126.852 2.595 . . . . 0.0 110.524 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.454 ' H ' HG12 ' A' ' 12' ' ' VAL . 24.5 m80 -100.9 -98.21 0.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 103.549 -2.76 . . . . 0.0 103.549 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -53.87 -25.2 18.7 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.481 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 29.1 tt0 -46.73 -47.71 20.55 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.139 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.434 ' H ' ' HG ' ' A' ' 17' ' ' LEU . 1.0 OUTLIER -82.98 -24.45 32.93 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.296 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.9 t -68.88 -18.7 23.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.481 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 17.9 m-85 -74.83 -23.65 58.48 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -84.71 -48.39 9.49 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.56 -34.58 71.21 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -57.6 -42.58 83.51 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.075 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.68 -51.9 50.88 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.392 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.3 t -51.78 -51.61 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 124.726 1.266 . . . . 0.0 111.038 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -38.22 101.23 0.01 OUTLIER Glycine 0 N--CA 1.498 2.786 0 O-C-N 124.337 1.023 . . . . 0.0 113.583 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.8 t 40.23 36.51 0.33 Allowed 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 114.394 -0.903 . . . . 0.0 113.331 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.9 p30 40.64 31.62 0.12 Allowed 'General case' 0 N--CA 1.504 2.248 0 O-C-N 124.354 1.034 . . . . 0.0 113.659 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt . . . . . 0 N--CA 1.502 2.126 0 CA-C-O 117.936 -1.031 . . . . 0.0 113.109 -179.883 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.3 t70 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.117 0.484 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.36 -82.11 0.21 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 102.745 -3.057 . . . . 0.0 102.745 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -162.97 91.97 0.75 Allowed 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.414 ' H ' ' H ' ' A' ' 5' ' ' ARG . 43.8 p90 -173.87 -15.68 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 113.145 -1.843 . . . . 0.0 109.285 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.414 ' H ' ' H ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -141.01 45.83 1.76 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 179.568 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -150.66 -48.54 0.12 Allowed 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 111.565 -2.562 . . . . 0.0 109.207 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -150.13 32.25 0.67 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.489 0.662 . . . . 0.0 109.945 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.31 41.25 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.746 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 146.13 51.31 0.03 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 107.074 -2.41 . . . . 0.0 107.074 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 24.7 p90 36.29 -146.32 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 O-C-N 125.222 1.19 . . . . 0.0 112.793 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -164.26 7.81 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.029 0.443 . . . . 0.0 111.325 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.0 t 69.61 -42.48 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 126.011 2.07 . . . . 0.0 114.694 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.3 m80 75.48 40.17 0.32 Allowed 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -139.07 -28.3 0.79 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 112.963 -1.926 . . . . 0.0 110.697 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -117.92 -41.28 2.91 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 124.579 1.174 . . . . 0.0 110.956 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.565 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 27.5 tt0 -59.13 -40.41 85.36 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 117.312 -1.755 . . . . 0.0 111.208 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.92 -15.25 61.58 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.627 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.7 t -76.29 -47.72 29.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.478 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.565 ' CE2' ' HA ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -72.49 -28.23 62.76 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 113.112 -1.858 . . . . 0.0 107.565 -179.499 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -72.22 -40.43 67.79 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.6 -45.97 87.95 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -65.28 -25.15 67.52 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 124.746 1.279 . . . . 0.0 111.151 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.57 -50.03 48.61 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.7 t -59.89 -47.6 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 159.76 -55.41 0.34 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 104.016 -3.634 . . . . 0.0 104.016 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.8 m -170.11 36.47 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.5 t30 55.71 30.37 15.46 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 114.252 -1.34 . . . . 0.0 110.689 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm . . . . . 0 N--CA 1.504 2.274 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.662 -179.816 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.583 0.706 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.79 -95.09 0.06 Allowed 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.168 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -156.34 83.44 0.98 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.423 ' C ' ' H ' ' A' ' 6' ' ' HIS . 94.8 m-85 -147.95 -62.91 0.26 Allowed 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 103.865 -2.643 . . . . 0.0 103.865 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.45 ' NE ' ' CD2' ' A' ' 6' ' ' HIS . 0.0 OUTLIER -76.28 8.1 3.67 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.288 -1.323 . . . . 0.0 111.59 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.45 ' CD2' ' NE ' ' A' ' 5' ' ' ARG . 28.6 m170 -99.95 -49.68 4.25 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 112.958 -1.928 . . . . 0.0 111.615 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.86 35.2 0.05 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 123.928 0.767 . . . . 0.0 111.757 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.37 36.88 0.11 Allowed 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 122.36 1.076 . . . . 0.0 108.437 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.419 ' H ' ' H ' ' A' ' 10' ' ' TYR . . . 146.05 15.23 0.18 Allowed Glycine 0 N--CA 1.495 2.609 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.419 ' H ' ' H ' ' A' ' 9' ' ' GLY . 13.3 p90 -70.13 173.99 5.98 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -83.8 117.85 23.55 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 113.67 -1.604 . . . . 0.0 109.993 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.539 HG12 ' H ' ' A' ' 14' ' ' HIS . 48.7 t -91.83 -55.69 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-N 112.283 -2.235 . . . . 0.0 112.383 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.48 ' H ' ' HB3' ' A' ' 16' ' ' GLU . 17.9 m-70 76.23 -2.5 2.72 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 125.355 1.659 . . . . 0.0 112.548 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.539 ' H ' HG12 ' A' ' 12' ' ' VAL . 12.1 m-70 -77.33 -50.37 12.96 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.794 0.807 . . . . 0.0 109.787 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -124.82 -31.03 3.21 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 112.695 -2.048 . . . . 0.0 108.454 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.48 ' HB3' ' H ' ' A' ' 13' ' ' HIS . 10.4 tt0 -46.01 -51.25 13.91 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 124.803 1.314 . . . . 0.0 110.493 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.483 HD12 ' C ' ' A' ' 17' ' ' LEU . 4.4 pp -82.69 -15.21 52.83 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 117.701 -1.6 . . . . 0.0 112.75 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.5 t -72.59 -18.9 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -75.21 -14.01 60.5 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.944 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.533 ' CZ ' HG21 ' A' ' 24' ' ' VAL . 1.5 t80 -103.03 -49.43 3.76 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.8 -15.06 57.8 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 113.992 -1.458 . . . . 0.0 107.122 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.42 -48.65 69.33 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -70.27 -59.28 2.97 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 113.449 -1.705 . . . . 0.0 112.369 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.533 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 2.5 t -59.68 -38.79 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.056 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.98 -51.92 54.37 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.0 t -55.39 -49.09 73.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 124.524 0.779 . . . . 0.0 109.918 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -50.91 -56.09 14.0 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 124.635 1.209 . . . . 0.0 110.015 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.4 ' HE3' HG12 ' A' ' 24' ' ' VAL . 15.2 mttp . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 116.59 -1.671 . . . . 0.0 110.436 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.133 0.492 . . . . 0.0 109.842 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.69 -61.63 1.9 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 105.82 -1.919 . . . . 0.0 105.82 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.449 ' HA ' ' CE1' ' A' ' 6' ' ' HIS . 0.0 OUTLIER -177.67 7.03 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 124.695 1.247 . . . . 0.0 113.053 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 5' ' ' ARG . 19.2 p90 -78.56 -46.28 19.8 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.275 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.403 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 16.6 ttm180 -48.05 -21.22 0.43 Allowed 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.449 ' CE1' ' HA ' ' A' ' 3' ' ' GLU . 40.2 m170 -55.28 -44.66 75.87 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 111.376 -2.647 . . . . 0.0 112.7 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -174.39 15.59 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.8 m -147.04 32.99 0.91 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 114.329 -1.305 . . . . 0.0 108.319 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -121.68 -41.38 0.49 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.413 ' CG ' ' N ' ' A' ' 11' ' ' GLU . 0.3 OUTLIER -141.57 -179.73 6.33 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 122.029 0.919 . . . . 0.0 110.081 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.413 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -172.44 141.72 1.21 Allowed 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 112.917 -1.947 . . . . 0.0 105.877 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.713 HG12 ' H ' ' A' ' 14' ' ' HIS . 3.5 t -143.01 -59.75 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.915 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.3 m80 65.31 -2.13 0.83 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 124.425 1.078 . . . . 0.0 112.299 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.713 ' H ' HG12 ' A' ' 12' ' ' VAL . 9.5 m-70 -89.6 -97.76 0.1 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 103.123 -2.917 . . . . 0.0 103.123 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.74 -28.5 65.92 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.46 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 34.0 tt0 -45.1 -48.94 11.99 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 113.545 -1.661 . . . . 0.0 112.477 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mt -86.35 -23.52 26.18 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.936 0.874 . . . . 0.0 109.551 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 14' ' ' HIS . 52.6 t -69.23 -15.45 19.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.46 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 22.7 m-85 -74.61 -22.98 58.66 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -86.01 -45.26 11.62 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 104.697 -2.334 . . . . 0.0 104.697 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.74 -31.41 68.29 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -65.28 -40.62 94.12 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 114.175 -1.375 . . . . 0.0 109.209 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.16 -49.27 74.99 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.096 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.1 t -53.28 -54.09 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 124.692 1.245 . . . . 0.0 108.609 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 157.12 -57.9 0.37 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 106.551 -2.62 . . . . 0.0 106.551 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.0 t -167.77 47.91 0.05 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.1 17.01 7.64 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.246 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 116.281 -1.819 . . . . 0.0 111.502 -179.926 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.74 -62.41 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.89 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -160.86 7.23 0.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.264 1.03 . . . . 0.0 111.711 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -74.04 -44.43 54.33 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 113.57 -1.65 . . . . 0.0 112.137 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.79 33.19 4.53 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 124.697 1.248 . . . . 0.0 110.908 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -137.99 -54.32 0.65 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 104.27 -2.492 . . . . 0.0 104.27 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -104.21 26.29 9.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 124.345 1.028 . . . . 0.0 109.595 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.6 m 47.37 38.72 7.83 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 113.991 -1.459 . . . . 0.0 111.15 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.13 -7.31 76.63 Favored Glycine 0 N--CA 1.497 2.72 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.219 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -59.32 175.24 0.33 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 124.289 0.641 . . . . 0.0 112.094 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -118.87 135.43 54.56 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.441 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.936 HG12 ' H ' ' A' ' 14' ' ' HIS . 2.6 t -138.03 -54.21 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-N 113.593 -1.64 . . . . 0.0 111.61 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.3 m170 78.76 -5.08 2.07 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 125.05 1.469 . . . . 0.0 112.933 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.936 ' H ' HG12 ' A' ' 12' ' ' VAL . 22.8 m-70 -98.26 -98.65 0.21 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -60.08 -19.35 52.76 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.445 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 27.7 tt0 -47.66 -52.44 18.15 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.553 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 pp -79.48 -18.93 50.96 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.352 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.6 t -71.05 -19.87 21.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.445 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 15.8 m-85 -76.06 -23.13 55.05 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -83.09 -49.93 9.02 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.1 -34.13 73.06 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -58.76 -41.81 87.45 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 113.886 -1.506 . . . . 0.0 110.064 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.72 -48.96 43.59 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.878 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.7 t -51.05 -52.71 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 124.411 1.07 . . . . 0.0 110.376 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 145.43 -133.15 4.93 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.1 m -147.84 46.8 1.1 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 61.08 9.22 2.28 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.949 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt . . . . . 0 N--CA 1.5 2.056 0 CA-C-O 117.582 -1.199 . . . . 0.0 112.397 -179.891 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.485 0.66 . . . . 0.0 109.26 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.59 55.97 3.84 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 122.299 1.047 . . . . 0.0 108.806 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.43 74.0 9.43 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 124.993 2.33 . . . . 0.0 110.824 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -158.26 -26.92 0.08 Allowed 'General case' 0 N--CA 1.495 1.784 1 CA-C-N 108.032 -4.167 . . . . 0.0 107.081 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -89.9 27.25 1.61 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.992 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 19.4 m80 68.32 53.96 0.57 Allowed 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 100.214 -3.995 . . . . 0.0 100.214 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.7 t70 60.87 56.13 2.98 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 111.36 -2.655 . . . . 0.0 111.579 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 65.02 28.91 12.39 Favored 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.425 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 72.4 61.03 3.8 Favored Glycine 0 N--CA 1.494 2.55 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.242 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -64.41 -168.71 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.442 0.639 . . . . 0.0 112.568 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.92 100.51 8.1 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.766 HG12 ' H ' ' A' ' 14' ' ' HIS . 42.8 t -55.32 -66.95 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 112.321 -2.218 . . . . 0.0 111.998 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 20.3 m80 58.29 7.07 0.61 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 124.099 0.874 . . . . 0.0 112.704 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.766 ' H ' HG12 ' A' ' 12' ' ' VAL . 3.3 m-70 -87.7 -76.19 0.39 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -85.77 -24.87 26.69 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 113.566 -1.652 . . . . 0.0 107.725 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.453 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 25.8 tt0 -46.25 -50.36 16.06 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 114.217 -1.356 . . . . 0.0 110.605 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.41 ' H ' ' HG ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -78.41 -22.18 48.16 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.274 -179.889 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.4 t -70.61 -19.67 21.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.453 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 14.3 m-30 -75.08 -24.03 58.09 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.83 -49.2 9.94 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.45 -33.39 69.67 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -61.47 -40.26 93.89 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.921 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.92 -48.59 57.94 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 124.567 1.167 . . . . 0.0 108.907 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 44.5 t -52.62 -53.2 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 124.652 1.22 . . . . 0.0 110.553 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 173.48 37.9 0.04 OUTLIER Glycine 0 N--CA 1.496 2.652 0 C-N-CA 119.898 -1.144 . . . . 0.0 112.942 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 78.3 p 42.52 27.67 0.1 Allowed 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -151.25 -70.12 0.17 Allowed 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 116.923 -1.513 . . . . 0.0 108.826 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 22.7 t70 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.99 -73.36 0.19 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.404 ' HA ' ' CE1' ' A' ' 6' ' ' HIS . 0.5 OUTLIER -172.49 21.32 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 179.802 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.424 ' C ' ' H ' ' A' ' 6' ' ' HIS . 9.2 p90 -104.96 -44.34 4.83 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.251 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.5 ttp85 -70.17 2.91 3.19 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 122.833 1.301 . . . . 0.0 113.176 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.424 ' H ' ' C ' ' A' ' 4' ' ' PHE . 17.2 m170 -76.12 -46.06 30.63 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 112.598 -2.092 . . . . 0.0 109.416 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -176.33 25.8 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 O-C-N 124.274 0.984 . . . . 0.0 112.009 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.9 t -161.59 45.68 0.17 Allowed 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.683 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.07 -41.62 0.05 OUTLIER Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -153.54 -166.46 2.41 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.448 ' C ' ' H ' ' A' ' 13' ' ' HIS . 0.9 OUTLIER -158.29 21.25 0.24 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 123.603 0.564 . . . . 0.0 112.057 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.0 t 72.49 -34.66 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 125.747 1.905 . . . . 0.0 112.027 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.448 ' H ' ' C ' ' A' ' 11' ' ' GLU . 0.8 OUTLIER 74.86 38.07 0.48 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -137.56 -79.54 0.37 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 112.909 -1.95 . . . . 0.0 107.231 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -51.77 -47.74 64.04 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.406 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.504 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 27.7 tt0 -49.64 -34.74 19.08 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.106 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 mt -81.41 -28.35 34.35 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 114.847 -1.069 . . . . 0.0 111.723 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.4 t -65.68 -26.92 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 C-N-CA 118.475 -1.29 . . . . 0.0 107.577 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.504 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 4.7 m-30 -71.37 -26.98 63.02 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 113.76 -1.564 . . . . 0.0 107.672 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -78.97 -47.99 15.31 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.86 -26.92 69.0 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -72.52 -22.7 60.99 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 118.714 -1.194 . . . . 0.0 111.763 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -99.22 -44.02 6.4 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 124.055 0.847 . . . . 0.0 113.193 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.9 t -102.72 -28.41 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 123.954 0.784 . . . . 0.0 112.24 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 41.23 61.19 2.11 Favored Glycine 0 N--CA 1.504 3.204 0 O-C-N 123.974 0.796 . . . . 0.0 113.142 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.9 p -149.07 -84.1 0.1 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 123.954 0.443 . . . . 0.0 110.607 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -81.69 -1.98 48.82 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 123.692 0.62 . . . . 0.0 111.055 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.415 ' HZ3' ' HB2' ' A' ' 28' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.503 2.215 0 CA-C-O 115.305 -2.283 . . . . 0.0 114.068 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.496 1.86 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 41.29 34.68 0.35 Allowed 'General case' 0 N--CA 1.509 2.517 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 48.04 18.84 0.16 Allowed 'General case' 0 N--CA 1.502 2.131 0 CA-C-N 114.603 -1.181 . . . . 0.0 114.093 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -65.91 -36.42 83.35 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.22 20.12 4.6 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 113.967 -1.469 . . . . 0.0 111.122 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.1 m80 -119.02 -51.87 2.33 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.431 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -130.67 35.12 4.04 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.2 p -176.68 34.4 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.234 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.492 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.47 76.72 0.03 OUTLIER Glycine 0 N--CA 1.494 2.534 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.466 ' CG ' ' N ' ' A' ' 11' ' ' GLU . 6.3 p90 -43.42 -40.78 3.92 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 121.339 0.59 . . . . 0.0 112.216 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.466 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 20.2 mt-10 39.11 106.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 126.043 2.089 . . . . 0.0 116.311 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.859 HG12 ' H ' ' A' ' 14' ' ' HIS . 44.3 t -126.93 -63.77 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-N 112.94 -1.936 . . . . 0.0 106.328 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.406 ' CD2' ' N ' ' A' ' 13' ' ' HIS . 12.1 m170 82.11 7.66 0.95 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 125.958 2.036 . . . . 0.0 112.024 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.859 ' H ' HG12 ' A' ' 12' ' ' VAL . 21.6 m-70 -104.68 -78.16 0.57 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 103.7 -2.704 . . . . 0.0 103.7 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -63.66 -17.67 63.17 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.658 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.641 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 32.0 tt0 -60.95 -48.59 81.1 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.596 -1.183 . . . . 0.0 110.621 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.04 -19.51 61.83 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.203 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.6 t -76.36 -41.79 36.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.868 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.641 ' CE2' ' HA ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -78.6 -19.79 51.95 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 125.28 1.613 . . . . 0.0 108.747 -179.595 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -79.91 -41.62 25.76 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.38 -33.67 74.68 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.407 ' HB3' ' HA ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -70.77 -27.56 64.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 124.938 1.399 . . . . 0.0 108.826 179.681 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -78.25 -54.33 6.34 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.894 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.1 t -78.16 -3.98 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 123.722 0.639 . . . . 0.0 110.466 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.02 74.45 0.34 Allowed Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.8 p 48.78 34.92 5.68 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 125.019 1.07 . . . . 0.0 111.124 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 58.14 61.52 2.3 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.494 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 116.779 -1.582 . . . . 0.0 110.444 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 120.714 0.292 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.72 -24.36 19.49 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.504 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 32.73 32.31 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 117.241 2.311 . . . . 0.0 117.241 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.465 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -74.35 14.19 0.48 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 113.11 -1.859 . . . . 0.0 110.277 179.563 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.409 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 10.0 mtm-85 55.81 27.56 11.06 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 122.75 1.262 . . . . 0.0 108.406 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.447 ' O ' ' CB ' ' A' ' 7' ' ' ASP . 17.4 m-70 52.88 17.08 0.8 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 111.213 -2.721 . . . . 0.0 111.093 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.447 ' CB ' ' O ' ' A' ' 6' ' ' HIS . 40.6 p-10 127.98 37.67 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.523 0 O-C-N 126.51 2.381 . . . . 0.0 111.647 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.409 ' HA ' ' HB2' ' A' ' 5' ' ' ARG . 4.1 p 59.59 32.8 21.8 Favored 'General case' 0 N--CA 1.506 2.372 0 CA-C-O 122.325 1.059 . . . . 0.0 110.916 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.12 68.7 0.15 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 105.473 -3.051 . . . . 0.0 105.473 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.71 167.19 7.69 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 114.079 1.141 . . . . 0.0 114.079 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.04 138.3 42.04 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 113.288 -1.778 . . . . 0.0 109.03 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.644 HG12 ' H ' ' A' ' 14' ' ' HIS . 42.5 t -153.86 -60.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.55 ' H ' ' HB3' ' A' ' 16' ' ' GLU . 1.8 m-70 74.87 -18.28 0.44 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 125.748 1.905 . . . . 0.0 113.166 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.644 ' H ' HG12 ' A' ' 12' ' ' VAL . 11.6 m-70 -57.31 -43.28 83.14 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.506 0.669 . . . . 0.0 109.392 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.1 -30.61 2.42 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 113.242 -1.799 . . . . 0.0 106.661 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.55 ' HB3' ' H ' ' A' ' 13' ' ' HIS . 42.6 tt0 -50.32 -48.23 55.43 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.191 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -79.26 -20.45 48.1 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.469 -1.292 . . . . 0.0 110.738 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.5 t -70.49 -19.34 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.413 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 16.9 m-30 -72.41 -25.02 61.32 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -82.15 -48.2 11.6 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.07 -25.35 65.32 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.19 -38.47 60.8 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 125.331 1.644 . . . . 0.0 108.35 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.08 -48.04 75.16 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.5 t -70.02 -17.7 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.382 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.69 52.77 48.54 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.1 t 53.13 30.39 9.67 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 124.564 0.803 . . . . 0.0 111.19 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 72.61 56.12 0.14 Allowed 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.713 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.985 0 CA-C-N 113.268 -1.787 . . . . 0.0 107.881 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 120.918 0.389 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.11 -24.53 67.45 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.661 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 63.92 101.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 124.558 1.161 . . . . 0.0 110.513 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.405 ' HA ' ' CD1' ' A' ' 10' ' ' TYR . 1.1 p90 -163.89 -38.92 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 114.207 -1.36 . . . . 0.0 109.992 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.429 ' HA ' ' NE ' ' A' ' 5' ' ' ARG . 5.7 mmp_? -74.97 -9.8 58.88 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-O 122.602 1.191 . . . . 0.0 110.397 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -61.48 -22.93 65.53 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 111.686 -2.506 . . . . 0.0 109.164 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -141.09 19.92 2.28 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 114.616 -1.174 . . . . 0.0 109.729 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.4 t 47.37 44.5 16.35 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 114.126 -1.397 . . . . 0.0 111.659 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.39 55.18 0.3 Allowed Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.405 ' CD1' ' HA ' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -60.17 -179.78 0.12 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.95 162.62 29.28 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.288 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.422 ' O ' ' HB2' ' A' ' 13' ' ' HIS . 74.0 t -143.55 -54.46 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.592 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.422 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 15.1 m-70 78.64 24.66 0.57 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 126.231 2.207 . . . . 0.0 112.346 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -119.3 -94.07 0.51 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 101.726 -3.435 . . . . 0.0 101.726 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -62.74 -20.9 65.39 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.416 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 30.3 tt0 -47.93 -52.18 20.56 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.896 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.65 -16.68 55.32 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.766 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.9 t -72.19 -21.38 20.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.416 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 12.8 m-85 -75.95 -23.95 55.44 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -80.74 -47.7 13.58 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.34 -40.18 81.46 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.64 -36.99 80.03 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 113.489 -1.687 . . . . 0.0 109.828 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.05 -49.38 65.33 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.55 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.7 t -54.31 -53.98 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 124.42 1.075 . . . . 0.0 109.526 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.96 -35.9 2.53 Favored Glycine 0 N--CA 1.496 2.672 0 O-C-N 124.053 0.846 . . . . 0.0 112.807 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.0 m -57.59 -31.71 66.46 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.107 0.479 . . . . 0.0 111.181 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -107.37 -7.09 16.78 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.103 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.826 0 O-C-N 124.505 1.128 . . . . 0.0 109.355 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.58 -27.43 13.41 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 124.079 0.862 . . . . 0.0 111.141 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 36.19 32.29 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.44 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -75.96 24.91 0.12 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 113.684 -1.598 . . . . 0.0 112.944 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.6 mtp85 56.34 28.59 13.69 Favored 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.427 ' CG ' ' HG2' ' A' ' 11' ' ' GLU . 0.1 OUTLIER 56.26 53.97 8.26 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 112.789 -2.005 . . . . 0.0 106.49 -179.519 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 64.43 36.7 8.71 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 113.318 -1.764 . . . . 0.0 111.19 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.7 m 62.53 64.82 0.89 Allowed 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 114.073 -1.421 . . . . 0.0 112.601 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.4 -83.06 0.16 Allowed Glycine 0 N--CA 1.484 1.888 1 N-CA-C 102.117 -4.393 . . . . 0.0 102.117 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -174.97 156.27 2.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 124.763 0.92 . . . . 0.0 109.899 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.427 ' HG2' ' CG ' ' A' ' 6' ' ' HIS . 18.8 mt-10 -134.04 109.14 8.77 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 122.206 1.003 . . . . 0.0 110.603 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.888 HG12 ' H ' ' A' ' 14' ' ' HIS . 41.7 t -129.14 -60.69 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-N 112.384 -2.189 . . . . 0.0 106.323 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.444 ' N ' ' CD2' ' A' ' 13' ' ' HIS . 6.8 m170 75.66 0.19 3.34 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 125.48 1.738 . . . . 0.0 111.943 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.888 ' H ' HG12 ' A' ' 12' ' ' VAL . 20.0 m-70 -93.81 -88.95 0.22 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -56.39 -27.05 55.13 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.455 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 24.4 tt0 -48.84 -48.03 42.11 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 114.072 -1.422 . . . . 0.0 109.151 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.51 -20.81 46.32 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 124.169 0.918 . . . . 0.0 111.858 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.7 t -70.27 -21.98 23.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.455 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 11.5 m-30 -74.39 -23.16 58.93 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -81.82 -44.19 17.26 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.35 -38.74 81.16 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -59.89 -36.9 77.93 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.525 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.59 -50.32 52.55 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.8 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.615 HG12 ' H ' ' A' ' 26' ' ' SER . 77.4 t -53.0 -56.54 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 124.55 1.157 . . . . 0.0 109.507 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.45 -1.24 0.3 Allowed Glycine 0 N--CA 1.499 2.839 0 O-C-N 124.073 0.858 . . . . 0.0 115.221 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.615 ' H ' HG12 ' A' ' 24' ' ' VAL . 47.7 m -75.63 -93.96 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -66.57 -18.97 65.66 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.6 mmtt . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 116.466 -1.731 . . . . 0.0 108.89 179.87 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.508 0.67 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.64 -16.77 63.44 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.151 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 54.81 18.09 2.01 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 124.686 1.241 . . . . 0.0 113.879 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -52.69 -58.6 6.3 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.06 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.419 ' H ' ' HD2' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -65.47 10.07 0.1 Allowed 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 116.792 2.145 . . . . 0.0 116.792 -179.637 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -92.37 -19.88 21.63 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -152.19 19.11 0.66 Allowed 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 114.418 -1.265 . . . . 0.0 108.827 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.0 t 53.03 25.1 3.84 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 121.874 0.845 . . . . 0.0 109.865 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 55.53 34.07 59.71 Favored Glycine 0 N--CA 1.497 2.702 0 CA-C-N 113.898 -1.501 . . . . 0.0 112.147 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.73 148.57 24.68 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 120.896 0.379 . . . . 0.0 110.921 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -141.49 128.82 21.13 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.501 HG12 ' H ' ' A' ' 14' ' ' HIS . 6.0 t -131.33 -62.23 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.067 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.536 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.4 OUTLIER 77.3 -22.72 0.27 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 125.328 1.643 . . . . 0.0 110.795 -179.869 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.501 ' H ' HG12 ' A' ' 12' ' ' VAL . 29.7 m-70 -75.17 -95.9 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.37 -27.23 62.11 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.484 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 29.2 tt0 -49.98 -46.15 52.26 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 113.889 -1.505 . . . . 0.0 108.955 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.536 HD23 ' O ' ' A' ' 13' ' ' HIS . 0.5 OUTLIER -78.52 -23.38 46.31 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.27 -0.972 . . . . 0.0 111.145 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.437 ' HA ' ' HB3' ' A' ' 21' ' ' ALA . 61.0 t -70.9 -17.15 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.484 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 15.0 m-30 -75.98 -15.6 60.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 124.437 1.085 . . . . 0.0 108.135 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -96.9 -48.53 5.4 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 18' ' ' VAL . . . -62.39 -16.52 55.23 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 114.038 -1.437 . . . . 0.0 107.403 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.46 -45.89 78.23 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -65.52 -48.07 73.78 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 114.007 -1.451 . . . . 0.0 107.969 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.5 t -59.23 -21.65 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.583 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.24 48.02 55.1 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 46.4 p 47.09 27.74 0.82 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 124.945 1.027 . . . . 0.0 112.828 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.9 m120 54.28 62.38 2.6 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 114.757 -1.111 . . . . 0.0 110.884 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.9 mtpp . . . . . 0 N--CA 1.499 2.019 0 CA-C-O 116.311 -1.804 . . . . 0.0 111.169 179.935 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.49 -107.85 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -168.75 27.27 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 121.792 0.806 . . . . 0.0 109.429 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -56.2 -63.55 1.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.35 -1.296 . . . . 0.0 111.12 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.88 17.8 0.3 Allowed 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -107.39 -56.19 2.24 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 114.313 -1.312 . . . . 0.0 107.817 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -165.08 35.82 0.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.946 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.5 t -158.56 32.17 0.23 Allowed 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 121.332 0.587 . . . . 0.0 111.631 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 177.15 -30.9 0.08 OUTLIER Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -63.61 175.77 1.01 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.809 0.814 . . . . 0.0 112.42 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -153.15 148.76 27.31 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.772 HG12 ' H ' ' A' ' 14' ' ' HIS . 2.4 t -139.16 -50.59 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 124.042 0.839 . . . . 0.0 110.917 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.9 m170 73.73 -7.35 1.6 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 124.583 1.177 . . . . 0.0 112.651 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.772 ' H ' HG12 ' A' ' 12' ' ' VAL . 20.7 m-70 -95.46 -97.63 0.17 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 103.468 -2.79 . . . . 0.0 103.468 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -55.83 -23.48 30.72 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.506 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 34.4 tt0 -48.29 -44.0 33.32 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 114.063 -1.426 . . . . 0.0 110.978 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.411 ' H ' ' HG ' ' A' ' 17' ' ' LEU . 1.0 OUTLIER -85.46 -24.39 27.44 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.632 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.6 t -69.4 -16.65 20.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.506 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 19.3 m-30 -75.31 -22.9 57.34 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -83.94 -48.13 10.3 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.3 -27.56 68.57 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -63.15 -42.37 99.45 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.474 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.77 -47.84 73.84 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.639 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 82.6 t -51.74 -52.32 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 124.688 1.243 . . . . 0.0 109.427 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.82 25.93 1.47 Allowed Glycine 0 N--CA 1.496 2.661 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.8 m 42.09 22.83 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 50.59 29.47 4.11 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.419 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 116.129 -1.891 . . . . 0.0 111.526 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.37 -24.14 4.0 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.517 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 38.76 31.61 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 125.448 1.717 . . . . 0.0 112.587 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -121.32 79.29 1.51 Allowed 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 113.073 -1.876 . . . . 0.0 106.182 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 91.6 56.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 111.148 -2.751 . . . . 0.0 106.112 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 58.0 46.32 16.63 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 112.225 -2.261 . . . . 0.0 107.065 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.5 t0 76.68 38.02 0.29 Allowed 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 113.355 -1.748 . . . . 0.0 110.212 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.1 m 64.63 75.73 0.36 Allowed 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 122.872 1.32 . . . . 0.0 110.256 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.35 -16.72 78.75 Favored Glycine 0 N--CA 1.491 2.313 0 CA-C-N 112.04 -2.345 . . . . 0.0 109.667 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -74.51 168.76 19.1 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 124.169 0.57 . . . . 0.0 111.009 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.23 26.36 0.1 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 118.045 2.609 . . . . 0.0 118.045 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.697 HG12 ' CD2' ' A' ' 14' ' ' HIS . 45.0 t 72.59 -58.27 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 125.525 1.766 . . . . 0.0 112.268 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 11.9 m170 90.41 -5.42 0.31 Allowed 'General case' 0 N--CA 1.505 2.281 0 O-C-N 126.336 2.273 . . . . 0.0 113.574 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.697 ' CD2' HG12 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -124.77 -65.86 1.01 Allowed 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.702 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.597 ' HB2' HG11 ' A' ' 12' ' ' VAL . 1.9 mp0 -54.37 -27.5 36.84 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.621 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.631 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 25.9 tt0 -64.29 -45.08 89.55 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.053 -1.059 . . . . 0.0 109.456 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.6 -20.95 62.71 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.832 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.9 t -75.14 -45.9 40.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.694 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.631 ' CE2' ' HA ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -76.25 -19.05 58.69 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.228 -1.351 . . . . 0.0 108.959 -179.621 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.595 ' O ' HG23 ' A' ' 24' ' ' VAL . 84.8 t80 -80.52 -39.43 27.86 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.4 -42.7 95.96 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.64 -35.39 76.07 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 113.628 -1.624 . . . . 0.0 109.524 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.16 -51.72 50.24 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.512 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 20' ' ' PHE . 38.5 t -51.74 -50.22 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 124.129 0.893 . . . . 0.0 109.784 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.17 41.02 9.67 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.0 p -131.12 -34.5 1.44 Allowed 'General case' 0 N--CA 1.499 1.975 0 CA-C-N 114.22 -0.99 . . . . 0.0 109.203 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.71 -17.46 12.1 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 113.315 -1.766 . . . . 0.0 108.571 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp . . . . . 0 N--CA 1.498 1.942 0 CA-C-O 114.788 -2.529 . . . . 0.0 110.96 179.94 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.9 t0 . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.83 -16.72 64.08 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.772 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 54.95 23.12 4.79 Favored 'General case' 0 N--CA 1.504 2.244 0 CA-C-O 122.69 1.233 . . . . 0.0 112.298 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.589 ' H ' ' NH2' ' A' ' 5' ' ' ARG . 20.6 t80 -53.43 -39.01 64.05 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 112.474 -2.148 . . . . 0.0 110.913 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.589 ' NH2' ' H ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -76.77 17.55 0.41 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 123.877 0.735 . . . . 0.0 112.887 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.408 ' H ' ' C ' ' A' ' 4' ' ' PHE . 11.2 m80 -131.16 -58.69 1.0 Allowed 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.785 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -85.19 9.27 15.55 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.345 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.0 t -170.53 24.69 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 113.361 -1.745 . . . . 0.0 108.811 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.55 -42.46 6.49 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -56.34 151.48 12.87 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 114.357 -0.921 . . . . 0.0 110.884 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -76.77 138.91 40.19 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 124.254 0.971 . . . . 0.0 110.497 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.454 HG12 ' H ' ' A' ' 14' ' ' HIS . 94.4 t -127.18 -56.68 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 113.219 -1.809 . . . . 0.0 107.569 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.43 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 12.0 m170 89.41 -2.25 0.36 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 126.852 2.595 . . . . 0.0 110.524 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.454 ' H ' HG12 ' A' ' 12' ' ' VAL . 24.5 m80 -100.9 -98.21 0.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 103.549 -2.76 . . . . 0.0 103.549 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -53.87 -25.2 18.7 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.481 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 29.1 tt0 -46.73 -47.71 20.55 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.139 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.434 ' H ' ' HG ' ' A' ' 17' ' ' LEU . 1.0 OUTLIER -82.98 -24.45 32.93 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.296 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.9 t -68.88 -18.7 23.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.481 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 17.9 m-85 -74.83 -23.65 58.48 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -84.71 -48.39 9.49 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.56 -34.58 71.21 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -57.6 -42.58 83.51 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.075 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.68 -51.9 50.88 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.392 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.3 t -51.78 -51.61 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 124.726 1.266 . . . . 0.0 111.038 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -38.22 101.23 0.01 OUTLIER Glycine 0 N--CA 1.498 2.786 0 O-C-N 124.337 1.023 . . . . 0.0 113.583 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.8 t 40.23 36.51 0.33 Allowed 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 114.394 -0.903 . . . . 0.0 113.331 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.9 p30 40.64 31.62 0.12 Allowed 'General case' 0 N--CA 1.504 2.248 0 O-C-N 124.354 1.034 . . . . 0.0 113.659 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt . . . . . 0 N--CA 1.502 2.126 0 CA-C-O 117.936 -1.031 . . . . 0.0 113.109 -179.883 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 24.7 p90 . . . . . 0 N--CA 1.504 2.241 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -164.26 7.81 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.029 0.443 . . . . 0.0 111.325 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.0 t 69.61 -42.48 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 126.011 2.07 . . . . 0.0 114.694 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.9 m170 75.48 40.17 0.32 Allowed 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -139.07 -28.3 0.79 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 112.963 -1.926 . . . . 0.0 110.697 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -117.92 -41.28 2.91 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 124.579 1.174 . . . . 0.0 110.956 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.565 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 27.5 tt0 -59.13 -40.41 85.36 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 117.312 -1.755 . . . . 0.0 111.208 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.92 -15.25 61.58 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.627 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.7 t -76.29 -47.72 29.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.478 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.565 ' CE2' ' HA ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -72.49 -28.23 62.76 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 113.112 -1.858 . . . . 0.0 107.565 -179.499 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -72.22 -40.43 67.79 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.6 -45.97 87.95 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -65.28 -25.15 67.52 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 124.746 1.279 . . . . 0.0 111.151 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.57 -50.03 48.61 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.7 t -59.89 -47.6 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 159.76 -55.41 0.34 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 104.016 -3.634 . . . . 0.0 104.016 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.8 m -170.11 36.47 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 55.71 30.37 15.46 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 114.252 -1.34 . . . . 0.0 110.689 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm . . . . . 0 N--CA 1.504 2.274 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.662 -179.816 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 13.3 p90 . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -83.8 117.85 23.55 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 113.67 -1.604 . . . . 0.0 109.993 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.539 HG12 ' H ' ' A' ' 14' ' ' HIS . 48.7 t -91.83 -55.69 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-N 112.283 -2.235 . . . . 0.0 112.383 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.48 ' H ' ' HB3' ' A' ' 16' ' ' GLU . 17.9 m-70 76.23 -2.5 2.72 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 125.355 1.659 . . . . 0.0 112.548 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.539 ' H ' HG12 ' A' ' 12' ' ' VAL . 12.1 m-70 -77.33 -50.37 12.96 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.794 0.807 . . . . 0.0 109.787 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -124.82 -31.03 3.21 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 112.695 -2.048 . . . . 0.0 108.454 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.48 ' HB3' ' H ' ' A' ' 13' ' ' HIS . 10.4 tt0 -46.01 -51.25 13.91 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 124.803 1.314 . . . . 0.0 110.493 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.483 HD12 ' C ' ' A' ' 17' ' ' LEU . 4.4 pp -82.69 -15.21 52.83 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 117.701 -1.6 . . . . 0.0 112.75 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.5 t -72.59 -18.9 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -75.21 -14.01 60.5 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.944 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.533 ' CZ ' HG21 ' A' ' 24' ' ' VAL . 1.5 t80 -103.03 -49.43 3.76 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.8 -15.06 57.8 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 113.992 -1.458 . . . . 0.0 107.122 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.42 -48.65 69.33 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -70.27 -59.28 2.97 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 113.449 -1.705 . . . . 0.0 112.369 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.533 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 2.5 t -59.68 -38.79 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.056 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.98 -51.92 54.37 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.0 t -55.39 -49.09 73.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 124.524 0.779 . . . . 0.0 109.918 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -50.91 -56.09 14.0 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 124.635 1.209 . . . . 0.0 110.015 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.4 ' HE3' HG12 ' A' ' 24' ' ' VAL . 15.2 mttp . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 116.59 -1.671 . . . . 0.0 110.436 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.413 ' CG ' ' N ' ' A' ' 11' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 122.029 0.919 . . . . 0.0 110.081 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.413 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -172.44 141.72 1.21 Allowed 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 112.917 -1.947 . . . . 0.0 105.877 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.713 HG12 ' H ' ' A' ' 14' ' ' HIS . 3.5 t -143.01 -59.75 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.915 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 65.31 -2.13 0.83 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 124.425 1.078 . . . . 0.0 112.299 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.713 ' H ' HG12 ' A' ' 12' ' ' VAL . 9.5 m-70 -89.6 -97.76 0.1 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 103.123 -2.917 . . . . 0.0 103.123 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -58.74 -28.5 65.92 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.46 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 34.0 tt0 -45.1 -48.94 11.99 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 113.545 -1.661 . . . . 0.0 112.477 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mt -86.35 -23.52 26.18 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.936 0.874 . . . . 0.0 109.551 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 14' ' ' HIS . 52.6 t -69.23 -15.45 19.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.46 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 22.7 m-85 -74.61 -22.98 58.66 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -86.01 -45.26 11.62 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 104.697 -2.334 . . . . 0.0 104.697 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.74 -31.41 68.29 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -65.28 -40.62 94.12 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 114.175 -1.375 . . . . 0.0 109.209 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.16 -49.27 74.99 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.096 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.1 t -53.28 -54.09 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 124.692 1.245 . . . . 0.0 108.609 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 157.12 -57.9 0.37 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 106.551 -2.62 . . . . 0.0 106.551 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.0 t -167.77 47.91 0.05 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 61.1 17.01 7.64 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.246 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 116.281 -1.819 . . . . 0.0 111.502 -179.926 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.9 p90 . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -118.87 135.43 54.56 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.441 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.936 HG12 ' H ' ' A' ' 14' ' ' HIS . 2.6 t -138.03 -54.21 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-N 113.593 -1.64 . . . . 0.0 111.61 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.3 m170 78.76 -5.08 2.07 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 125.05 1.469 . . . . 0.0 112.933 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.936 ' H ' HG12 ' A' ' 12' ' ' VAL . 22.8 m-70 -98.26 -98.65 0.21 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -60.08 -19.35 52.76 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.445 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 27.7 tt0 -47.66 -52.44 18.15 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.553 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 pp -79.48 -18.93 50.96 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.352 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.6 t -71.05 -19.87 21.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.445 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 15.8 m-85 -76.06 -23.13 55.05 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -83.09 -49.93 9.02 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.1 -34.13 73.06 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -58.76 -41.81 87.45 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 113.886 -1.506 . . . . 0.0 110.064 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.72 -48.96 43.59 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.878 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.7 t -51.05 -52.71 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 124.411 1.07 . . . . 0.0 110.376 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 145.43 -133.15 4.93 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.1 m -147.84 46.8 1.1 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 61.08 9.22 2.28 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.949 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt . . . . . 0 N--CA 1.5 2.056 0 CA-C-O 117.582 -1.199 . . . . 0.0 112.397 -179.891 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 121.442 0.639 . . . . 0.0 112.568 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.92 100.51 8.1 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.766 HG12 ' H ' ' A' ' 14' ' ' HIS . 42.8 t -55.32 -66.95 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 112.321 -2.218 . . . . 0.0 111.998 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 58.29 7.07 0.61 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 124.099 0.874 . . . . 0.0 112.704 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.766 ' H ' HG12 ' A' ' 12' ' ' VAL . 3.3 m-70 -87.7 -76.19 0.39 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -85.77 -24.87 26.69 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 113.566 -1.652 . . . . 0.0 107.725 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.453 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 25.8 tt0 -46.25 -50.36 16.06 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 114.217 -1.356 . . . . 0.0 110.605 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.41 ' H ' ' HG ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -78.41 -22.18 48.16 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.274 -179.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.4 t -70.61 -19.67 21.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.453 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 14.3 m-30 -75.08 -24.03 58.09 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.83 -49.2 9.94 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.45 -33.39 69.67 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -61.47 -40.26 93.89 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.921 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.92 -48.59 57.94 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 124.567 1.167 . . . . 0.0 108.907 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 44.5 t -52.62 -53.2 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 124.652 1.22 . . . . 0.0 110.553 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 173.48 37.9 0.04 OUTLIER Glycine 0 N--CA 1.496 2.652 0 C-N-CA 119.898 -1.144 . . . . 0.0 112.942 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 78.3 p 42.52 27.67 0.1 Allowed 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -151.25 -70.12 0.17 Allowed 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 116.923 -1.513 . . . . 0.0 108.826 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.448 ' C ' ' H ' ' A' ' 13' ' ' HIS . 0.9 OUTLIER -158.29 21.25 0.24 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 123.603 0.564 . . . . 0.0 112.057 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.0 t 72.49 -34.66 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 125.747 1.905 . . . . 0.0 112.027 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.448 ' H ' ' C ' ' A' ' 11' ' ' GLU . 6.5 m170 74.86 38.07 0.48 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -137.56 -79.54 0.37 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 112.909 -1.95 . . . . 0.0 107.231 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -51.77 -47.74 64.04 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.406 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.504 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 27.7 tt0 -49.64 -34.74 19.08 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.106 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 mt -81.41 -28.35 34.35 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 114.847 -1.069 . . . . 0.0 111.723 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.4 t -65.68 -26.92 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 C-N-CA 118.475 -1.29 . . . . 0.0 107.577 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.504 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 4.7 m-30 -71.37 -26.98 63.02 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 113.76 -1.564 . . . . 0.0 107.672 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -78.97 -47.99 15.31 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.86 -26.92 69.0 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -72.52 -22.7 60.99 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 118.714 -1.194 . . . . 0.0 111.763 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -99.22 -44.02 6.4 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 124.055 0.847 . . . . 0.0 113.193 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.9 t -102.72 -28.41 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 123.954 0.784 . . . . 0.0 112.24 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 41.23 61.19 2.11 Favored Glycine 0 N--CA 1.504 3.204 0 O-C-N 123.974 0.796 . . . . 0.0 113.142 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.9 p -149.07 -84.1 0.1 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 123.954 0.443 . . . . 0.0 110.607 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -81.69 -1.98 48.82 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 123.692 0.62 . . . . 0.0 111.055 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.415 ' HZ3' ' HB2' ' A' ' 28' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.503 2.215 0 CA-C-O 115.305 -2.283 . . . . 0.0 114.068 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.466 ' CG ' ' N ' ' A' ' 11' ' ' GLU . 6.3 p90 . . . . . 0 N--CA 1.503 2.207 0 CA-C-O 121.339 0.59 . . . . 0.0 112.216 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.466 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 20.2 mt-10 39.11 106.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 126.043 2.089 . . . . 0.0 116.311 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.859 HG12 ' H ' ' A' ' 14' ' ' HIS . 44.3 t -126.93 -63.77 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-N 112.94 -1.936 . . . . 0.0 106.328 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.406 ' CD2' ' N ' ' A' ' 13' ' ' HIS . 12.1 m170 82.11 7.66 0.95 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 125.958 2.036 . . . . 0.0 112.024 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.859 ' H ' HG12 ' A' ' 12' ' ' VAL . 21.6 m-70 -104.68 -78.16 0.57 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 103.7 -2.704 . . . . 0.0 103.7 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -63.66 -17.67 63.17 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.658 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.641 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 32.0 tt0 -60.95 -48.59 81.1 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.596 -1.183 . . . . 0.0 110.621 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.04 -19.51 61.83 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.203 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.6 t -76.36 -41.79 36.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.868 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.641 ' CE2' ' HA ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -78.6 -19.79 51.95 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 125.28 1.613 . . . . 0.0 108.747 -179.595 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -79.91 -41.62 25.76 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.38 -33.67 74.68 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.407 ' HB3' ' HA ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -70.77 -27.56 64.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 124.938 1.399 . . . . 0.0 108.826 179.681 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -78.25 -54.33 6.34 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.894 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.1 t -78.16 -3.98 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 123.722 0.639 . . . . 0.0 110.466 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.02 74.45 0.34 Allowed Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.8 p 48.78 34.92 5.68 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 125.019 1.07 . . . . 0.0 111.124 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 58.14 61.52 2.3 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.494 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 116.779 -1.582 . . . . 0.0 110.444 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 114.079 1.141 . . . . 0.0 114.079 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.04 138.3 42.04 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 113.288 -1.778 . . . . 0.0 109.03 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.644 HG12 ' H ' ' A' ' 14' ' ' HIS . 42.5 t -153.86 -60.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.55 ' H ' ' HB3' ' A' ' 16' ' ' GLU . 8.3 m170 74.87 -18.28 0.44 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 125.748 1.905 . . . . 0.0 113.166 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.644 ' H ' HG12 ' A' ' 12' ' ' VAL . 11.6 m-70 -57.31 -43.28 83.14 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.506 0.669 . . . . 0.0 109.392 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.1 -30.61 2.42 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 113.242 -1.799 . . . . 0.0 106.661 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.55 ' HB3' ' H ' ' A' ' 13' ' ' HIS . 42.6 tt0 -50.32 -48.23 55.43 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.191 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -79.26 -20.45 48.1 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.469 -1.292 . . . . 0.0 110.738 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.5 t -70.49 -19.34 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.413 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 16.9 m-30 -72.41 -25.02 61.32 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -82.15 -48.2 11.6 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.07 -25.35 65.32 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.19 -38.47 60.8 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 125.331 1.644 . . . . 0.0 108.35 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.08 -48.04 75.16 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.5 t -70.02 -17.7 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.382 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.69 52.77 48.54 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.1 t 53.13 30.39 9.67 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 124.564 0.803 . . . . 0.0 111.19 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 72.61 56.12 0.14 Allowed 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.713 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.985 0 CA-C-N 113.268 -1.787 . . . . 0.0 107.881 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.927 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.95 162.62 29.28 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.288 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.422 ' O ' ' HB2' ' A' ' 13' ' ' HIS . 74.0 t -143.55 -54.46 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.592 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.422 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 15.1 m-70 78.64 24.66 0.57 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 126.231 2.207 . . . . 0.0 112.346 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -119.3 -94.07 0.51 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 101.726 -3.435 . . . . 0.0 101.726 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -62.74 -20.9 65.39 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.416 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 30.3 tt0 -47.93 -52.18 20.56 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.896 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.65 -16.68 55.32 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.766 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.9 t -72.19 -21.38 20.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.416 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 12.8 m-85 -75.95 -23.95 55.44 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -80.74 -47.7 13.58 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.45 ' HB1' ' ND2' ' A' ' 27' ' ' ASN . . . -58.34 -40.18 81.46 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.64 -36.99 80.03 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 113.489 -1.687 . . . . 0.0 109.828 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.05 -49.38 65.33 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.55 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.7 t -54.31 -53.98 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 124.42 1.075 . . . . 0.0 109.526 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.96 -35.9 2.53 Favored Glycine 0 N--CA 1.496 2.672 0 O-C-N 124.053 0.846 . . . . 0.0 112.807 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.0 m -57.59 -31.71 66.46 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.107 0.479 . . . . 0.0 111.181 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.45 ' ND2' ' HB1' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -107.37 -7.09 16.78 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.103 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.826 0 O-C-N 124.505 1.128 . . . . 0.0 109.355 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.6 p90 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -134.04 109.14 8.77 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 122.206 1.003 . . . . 0.0 110.603 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.888 HG12 ' H ' ' A' ' 14' ' ' HIS . 41.7 t -129.14 -60.69 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-N 112.384 -2.189 . . . . 0.0 106.323 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.444 ' N ' ' CD2' ' A' ' 13' ' ' HIS . 6.8 m170 75.66 0.19 3.34 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 125.48 1.738 . . . . 0.0 111.943 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.888 ' H ' HG12 ' A' ' 12' ' ' VAL . 20.0 m-70 -93.81 -88.95 0.22 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -56.39 -27.05 55.13 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.455 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 24.4 tt0 -48.84 -48.03 42.11 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 114.072 -1.422 . . . . 0.0 109.151 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.51 -20.81 46.32 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 124.169 0.918 . . . . 0.0 111.858 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.7 t -70.27 -21.98 23.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.455 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 11.5 m-30 -74.39 -23.16 58.93 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -81.82 -44.19 17.26 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.35 -38.74 81.16 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -59.89 -36.9 77.93 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.525 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.59 -50.32 52.55 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.8 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.615 HG12 ' H ' ' A' ' 26' ' ' SER . 77.4 t -53.0 -56.54 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 124.55 1.157 . . . . 0.0 109.507 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.45 -1.24 0.3 Allowed Glycine 0 N--CA 1.499 2.839 0 O-C-N 124.073 0.858 . . . . 0.0 115.221 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.615 ' H ' HG12 ' A' ' 24' ' ' VAL . 47.7 m -75.63 -93.96 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -66.57 -18.97 65.66 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.6 mmtt . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 116.466 -1.731 . . . . 0.0 108.89 179.87 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 120.896 0.379 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -141.49 128.82 21.13 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.501 HG12 ' H ' ' A' ' 14' ' ' HIS . 6.0 t -131.33 -62.23 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.067 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.536 ' O ' HD23 ' A' ' 17' ' ' LEU . 7.4 m170 77.3 -22.72 0.27 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 125.328 1.643 . . . . 0.0 110.795 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.501 ' H ' HG12 ' A' ' 12' ' ' VAL . 29.7 m-70 -75.17 -95.9 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.37 -27.23 62.11 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.484 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 29.2 tt0 -49.98 -46.15 52.26 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 113.889 -1.505 . . . . 0.0 108.955 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.536 HD23 ' O ' ' A' ' 13' ' ' HIS . 0.5 OUTLIER -78.52 -23.38 46.31 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.27 -0.972 . . . . 0.0 111.145 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.437 ' HA ' ' HB3' ' A' ' 21' ' ' ALA . 61.0 t -70.9 -17.15 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.484 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 15.0 m-30 -75.98 -15.6 60.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 124.437 1.085 . . . . 0.0 108.135 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -96.9 -48.53 5.4 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 18' ' ' VAL . . . -62.39 -16.52 55.23 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 114.038 -1.437 . . . . 0.0 107.403 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.46 -45.89 78.23 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -65.52 -48.07 73.78 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 114.007 -1.451 . . . . 0.0 107.969 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.5 t -59.23 -21.65 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.583 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.24 48.02 55.1 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 46.4 p 47.09 27.74 0.82 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 124.945 1.027 . . . . 0.0 112.828 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 54.28 62.38 2.6 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 114.757 -1.111 . . . . 0.0 110.884 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.9 mtpp . . . . . 0 N--CA 1.499 2.019 0 CA-C-O 116.311 -1.804 . . . . 0.0 111.169 179.935 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.809 0.814 . . . . 0.0 112.42 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -153.15 148.76 27.31 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.772 HG12 ' H ' ' A' ' 14' ' ' HIS . 2.4 t -139.16 -50.59 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 124.042 0.839 . . . . 0.0 110.917 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.9 m170 73.73 -7.35 1.6 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 124.583 1.177 . . . . 0.0 112.651 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.772 ' H ' HG12 ' A' ' 12' ' ' VAL . 20.7 m-70 -95.46 -97.63 0.17 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 103.468 -2.79 . . . . 0.0 103.468 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -55.83 -23.48 30.72 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.506 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 34.4 tt0 -48.29 -44.0 33.32 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 114.063 -1.426 . . . . 0.0 110.978 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.411 ' H ' ' HG ' ' A' ' 17' ' ' LEU . 1.0 OUTLIER -85.46 -24.39 27.44 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.632 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.6 t -69.4 -16.65 20.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.506 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 19.3 m-30 -75.31 -22.9 57.34 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -83.94 -48.13 10.3 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.3 -27.56 68.57 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -63.15 -42.37 99.45 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.474 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.77 -47.84 73.84 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.639 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 82.6 t -51.74 -52.32 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 124.688 1.243 . . . . 0.0 109.427 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.82 25.93 1.47 Allowed Glycine 0 N--CA 1.496 2.661 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.8 m 42.09 22.83 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 50.59 29.47 4.11 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.419 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 116.129 -1.891 . . . . 0.0 111.526 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 43.9 p90 . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 120.991 0.424 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.23 26.36 0.1 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 118.045 2.609 . . . . 0.0 118.045 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.697 HG12 ' CD2' ' A' ' 14' ' ' HIS . 45.0 t 72.59 -58.27 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 125.525 1.766 . . . . 0.0 112.268 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 11.9 m170 90.41 -5.42 0.31 Allowed 'General case' 0 N--CA 1.505 2.281 0 O-C-N 126.336 2.273 . . . . 0.0 113.574 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.697 ' CD2' HG12 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -124.77 -65.86 1.01 Allowed 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.702 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.597 ' HB2' HG11 ' A' ' 12' ' ' VAL . 1.6 mp0 -54.37 -27.5 36.84 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.621 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.631 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 25.9 tt0 -64.29 -45.08 89.55 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.053 -1.059 . . . . 0.0 109.456 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.6 -20.95 62.71 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.832 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.9 t -75.14 -45.9 40.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.694 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.631 ' CE2' ' HA ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -76.25 -19.05 58.69 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.228 -1.351 . . . . 0.0 108.959 -179.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.595 ' O ' HG23 ' A' ' 24' ' ' VAL . 84.8 t80 -80.52 -39.43 27.86 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.4 -42.7 95.96 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.64 -35.39 76.07 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 113.628 -1.624 . . . . 0.0 109.524 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.16 -51.72 50.24 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.512 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 20' ' ' PHE . 38.5 t -51.74 -50.22 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 124.129 0.893 . . . . 0.0 109.784 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.17 41.02 9.67 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.0 p -131.12 -34.5 1.44 Allowed 'General case' 0 N--CA 1.499 1.975 0 CA-C-N 114.22 -0.99 . . . . 0.0 109.203 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.503 ' H ' ' ND2' ' A' ' 27' ' ' ASN . 0.0 OUTLIER -113.71 -17.46 12.1 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 113.315 -1.766 . . . . 0.0 108.571 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp . . . . . 0 N--CA 1.498 1.942 0 CA-C-O 114.788 -2.529 . . . . 0.0 110.96 179.94 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.7 p90 . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 120.588 0.232 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -76.77 138.91 40.19 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 124.254 0.971 . . . . 0.0 110.497 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.454 HG12 ' H ' ' A' ' 14' ' ' HIS . 94.4 t -127.18 -56.68 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 113.219 -1.809 . . . . 0.0 107.569 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.43 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 12.0 m170 89.41 -2.25 0.36 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 126.852 2.595 . . . . 0.0 110.524 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.454 ' H ' HG12 ' A' ' 12' ' ' VAL . 21.6 m-70 -100.9 -98.21 0.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 103.549 -2.76 . . . . 0.0 103.549 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -53.87 -25.2 18.7 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.481 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 29.1 tt0 -46.73 -47.71 20.55 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.139 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.434 ' H ' ' HG ' ' A' ' 17' ' ' LEU . 1.0 OUTLIER -82.98 -24.45 32.93 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.296 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.9 t -68.88 -18.7 23.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.481 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 17.9 m-85 -74.83 -23.65 58.48 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -84.71 -48.39 9.49 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.56 -34.58 71.21 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -57.6 -42.58 83.51 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.075 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.68 -51.9 50.88 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.392 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.3 t -51.78 -51.61 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 124.726 1.266 . . . . 0.0 111.038 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -38.22 101.23 0.01 OUTLIER Glycine 0 N--CA 1.498 2.786 0 O-C-N 124.337 1.023 . . . . 0.0 113.583 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.8 t 40.23 36.51 0.33 Allowed 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 114.394 -0.903 . . . . 0.0 113.331 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.9 p30 40.64 31.62 0.12 Allowed 'General case' 0 N--CA 1.504 2.248 0 O-C-N 124.354 1.034 . . . . 0.0 113.659 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt . . . . . 0 N--CA 1.502 2.126 0 CA-C-O 117.936 -1.031 . . . . 0.0 113.109 -179.883 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.3 t70 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.117 0.484 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.36 -82.11 0.21 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 102.745 -3.057 . . . . 0.0 102.745 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -162.97 91.97 0.75 Allowed 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.414 ' H ' ' H ' ' A' ' 5' ' ' ARG . 43.8 p90 -173.87 -15.68 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 113.145 -1.843 . . . . 0.0 109.285 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.414 ' H ' ' H ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -141.01 45.83 1.76 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 179.568 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -150.66 -48.54 0.12 Allowed 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 111.565 -2.562 . . . . 0.0 109.207 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -150.13 32.25 0.67 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.489 0.662 . . . . 0.0 109.945 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.31 41.25 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.746 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 146.13 51.31 0.03 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 107.074 -2.41 . . . . 0.0 107.074 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 24.7 p90 36.29 -146.32 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 O-C-N 125.222 1.19 . . . . 0.0 112.793 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -164.26 7.81 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.029 0.443 . . . . 0.0 111.325 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.0 t 69.61 -42.48 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 126.011 2.07 . . . . 0.0 114.694 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.9 m170 75.48 40.17 0.32 Allowed 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -139.07 -28.3 0.79 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 112.963 -1.926 . . . . 0.0 110.697 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -117.92 -41.28 2.91 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 124.579 1.174 . . . . 0.0 110.956 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.565 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 27.5 tt0 -59.13 -40.41 85.36 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 117.312 -1.755 . . . . 0.0 111.208 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.92 -15.25 61.58 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.627 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.7 t -76.29 -47.72 29.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.478 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.565 ' CE2' ' HA ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -72.49 -28.23 62.76 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 113.112 -1.858 . . . . 0.0 107.565 -179.499 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -72.22 -40.43 67.79 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.6 -45.97 87.95 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -65.28 -25.15 67.52 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 124.746 1.279 . . . . 0.0 111.151 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.57 -50.03 48.61 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.7 t -59.89 -47.6 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 159.76 -55.41 0.34 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 104.016 -3.634 . . . . 0.0 104.016 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.8 m -170.11 36.47 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 55.71 30.37 15.46 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 114.252 -1.34 . . . . 0.0 110.689 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm . . . . . 0 N--CA 1.504 2.274 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.662 -179.816 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.583 0.706 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.79 -95.09 0.06 Allowed 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.168 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -156.34 83.44 0.98 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.423 ' C ' ' H ' ' A' ' 6' ' ' HIS . 94.8 m-85 -147.95 -62.91 0.26 Allowed 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 103.865 -2.643 . . . . 0.0 103.865 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.45 ' NE ' ' CD2' ' A' ' 6' ' ' HIS . 0.0 OUTLIER -76.28 8.1 3.67 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.288 -1.323 . . . . 0.0 111.59 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.45 ' CD2' ' NE ' ' A' ' 5' ' ' ARG . 28.6 m170 -99.95 -49.68 4.25 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 112.958 -1.928 . . . . 0.0 111.615 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.86 35.2 0.05 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 123.928 0.767 . . . . 0.0 111.757 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.37 36.88 0.11 Allowed 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 122.36 1.076 . . . . 0.0 108.437 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.419 ' H ' ' H ' ' A' ' 10' ' ' TYR . . . 146.05 15.23 0.18 Allowed Glycine 0 N--CA 1.495 2.609 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.419 ' H ' ' H ' ' A' ' 9' ' ' GLY . 13.3 p90 -70.13 173.99 5.98 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -83.8 117.85 23.55 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 113.67 -1.604 . . . . 0.0 109.993 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.539 HG12 ' H ' ' A' ' 14' ' ' HIS . 48.7 t -91.83 -55.69 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-N 112.283 -2.235 . . . . 0.0 112.383 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.48 ' H ' ' HB3' ' A' ' 16' ' ' GLU . 17.9 m-70 76.23 -2.5 2.72 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 125.355 1.659 . . . . 0.0 112.548 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.539 ' H ' HG12 ' A' ' 12' ' ' VAL . 12.1 m-70 -77.33 -50.37 12.96 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.794 0.807 . . . . 0.0 109.787 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -124.82 -31.03 3.21 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 112.695 -2.048 . . . . 0.0 108.454 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.48 ' HB3' ' H ' ' A' ' 13' ' ' HIS . 10.4 tt0 -46.01 -51.25 13.91 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 124.803 1.314 . . . . 0.0 110.493 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.483 HD12 ' C ' ' A' ' 17' ' ' LEU . 4.4 pp -82.69 -15.21 52.83 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 117.701 -1.6 . . . . 0.0 112.75 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.5 t -72.59 -18.9 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -75.21 -14.01 60.5 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.944 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.533 ' CZ ' HG21 ' A' ' 24' ' ' VAL . 1.5 t80 -103.03 -49.43 3.76 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.8 -15.06 57.8 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 113.992 -1.458 . . . . 0.0 107.122 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.42 -48.65 69.33 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -70.27 -59.28 2.97 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 113.449 -1.705 . . . . 0.0 112.369 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.533 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 2.5 t -59.68 -38.79 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.056 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.98 -51.92 54.37 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.0 t -55.39 -49.09 73.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 124.524 0.779 . . . . 0.0 109.918 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -50.91 -56.09 14.0 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 124.635 1.209 . . . . 0.0 110.015 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.4 ' HE3' HG12 ' A' ' 24' ' ' VAL . 15.2 mttp . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 116.59 -1.671 . . . . 0.0 110.436 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.133 0.492 . . . . 0.0 109.842 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.69 -61.63 1.9 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 105.82 -1.919 . . . . 0.0 105.82 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.449 ' HA ' ' CE1' ' A' ' 6' ' ' HIS . 0.0 OUTLIER -177.67 7.03 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 124.695 1.247 . . . . 0.0 113.053 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 5' ' ' ARG . 19.2 p90 -78.56 -46.28 19.8 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.275 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.403 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 16.6 ttm180 -48.05 -21.22 0.43 Allowed 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.449 ' CE1' ' HA ' ' A' ' 3' ' ' GLU . 40.2 m170 -55.28 -44.66 75.87 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 111.376 -2.647 . . . . 0.0 112.7 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -174.39 15.59 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.8 m -147.04 32.99 0.91 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 114.329 -1.305 . . . . 0.0 108.319 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -121.68 -41.38 0.49 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.413 ' CG ' ' N ' ' A' ' 11' ' ' GLU . 0.3 OUTLIER -141.57 -179.73 6.33 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 122.029 0.919 . . . . 0.0 110.081 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.413 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -172.44 141.72 1.21 Allowed 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 112.917 -1.947 . . . . 0.0 105.877 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.713 HG12 ' H ' ' A' ' 14' ' ' HIS . 3.5 t -143.01 -59.75 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.915 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 65.31 -2.13 0.83 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 124.425 1.078 . . . . 0.0 112.299 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.713 ' H ' HG12 ' A' ' 12' ' ' VAL . 9.5 m-70 -89.6 -97.76 0.1 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 103.123 -2.917 . . . . 0.0 103.123 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -58.74 -28.5 65.92 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.46 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 34.0 tt0 -45.1 -48.94 11.99 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 113.545 -1.661 . . . . 0.0 112.477 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mt -86.35 -23.52 26.18 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.936 0.874 . . . . 0.0 109.551 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 14' ' ' HIS . 52.6 t -69.23 -15.45 19.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.46 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 22.7 m-85 -74.61 -22.98 58.66 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -86.01 -45.26 11.62 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 104.697 -2.334 . . . . 0.0 104.697 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.74 -31.41 68.29 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -65.28 -40.62 94.12 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 114.175 -1.375 . . . . 0.0 109.209 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.16 -49.27 74.99 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.096 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.1 t -53.28 -54.09 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 124.692 1.245 . . . . 0.0 108.609 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 157.12 -57.9 0.37 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 106.551 -2.62 . . . . 0.0 106.551 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.0 t -167.77 47.91 0.05 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 61.1 17.01 7.64 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.246 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 116.281 -1.819 . . . . 0.0 111.502 -179.926 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.74 -62.41 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.89 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -160.86 7.23 0.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.264 1.03 . . . . 0.0 111.711 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -74.04 -44.43 54.33 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 113.57 -1.65 . . . . 0.0 112.137 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.79 33.19 4.53 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 124.697 1.248 . . . . 0.0 110.908 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -137.99 -54.32 0.65 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 104.27 -2.492 . . . . 0.0 104.27 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -104.21 26.29 9.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 124.345 1.028 . . . . 0.0 109.595 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.6 m 47.37 38.72 7.83 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 113.991 -1.459 . . . . 0.0 111.15 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.13 -7.31 76.63 Favored Glycine 0 N--CA 1.497 2.72 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.219 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -59.32 175.24 0.33 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 124.289 0.641 . . . . 0.0 112.094 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -118.87 135.43 54.56 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.441 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.936 HG12 ' H ' ' A' ' 14' ' ' HIS . 2.6 t -138.03 -54.21 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-N 113.593 -1.64 . . . . 0.0 111.61 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.3 m170 78.76 -5.08 2.07 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 125.05 1.469 . . . . 0.0 112.933 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.936 ' H ' HG12 ' A' ' 12' ' ' VAL . 22.8 m-70 -98.26 -98.65 0.21 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -60.08 -19.35 52.76 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.445 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 27.7 tt0 -47.66 -52.44 18.15 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.553 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 pp -79.48 -18.93 50.96 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.352 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.6 t -71.05 -19.87 21.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.445 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 15.8 m-85 -76.06 -23.13 55.05 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -83.09 -49.93 9.02 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.1 -34.13 73.06 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -58.76 -41.81 87.45 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 113.886 -1.506 . . . . 0.0 110.064 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.72 -48.96 43.59 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.878 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.7 t -51.05 -52.71 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 124.411 1.07 . . . . 0.0 110.376 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 145.43 -133.15 4.93 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.1 m -147.84 46.8 1.1 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 61.08 9.22 2.28 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.949 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt . . . . . 0 N--CA 1.5 2.056 0 CA-C-O 117.582 -1.199 . . . . 0.0 112.397 -179.891 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.485 0.66 . . . . 0.0 109.26 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.59 55.97 3.84 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 122.299 1.047 . . . . 0.0 108.806 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.43 74.0 9.43 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 124.993 2.33 . . . . 0.0 110.824 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -158.26 -26.92 0.08 Allowed 'General case' 0 N--CA 1.495 1.784 1 CA-C-N 108.032 -4.167 . . . . 0.0 107.081 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -89.9 27.25 1.61 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.992 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 19.4 m80 68.32 53.96 0.57 Allowed 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 100.214 -3.995 . . . . 0.0 100.214 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.7 t70 60.87 56.13 2.98 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 111.36 -2.655 . . . . 0.0 111.579 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 65.02 28.91 12.39 Favored 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.425 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 72.4 61.03 3.8 Favored Glycine 0 N--CA 1.494 2.55 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.242 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -64.41 -168.71 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.442 0.639 . . . . 0.0 112.568 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.92 100.51 8.1 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.766 HG12 ' H ' ' A' ' 14' ' ' HIS . 42.8 t -55.32 -66.95 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 112.321 -2.218 . . . . 0.0 111.998 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 58.29 7.07 0.61 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 124.099 0.874 . . . . 0.0 112.704 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.766 ' H ' HG12 ' A' ' 12' ' ' VAL . 3.3 m-70 -87.7 -76.19 0.39 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -85.77 -24.87 26.69 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 113.566 -1.652 . . . . 0.0 107.725 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.453 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 25.8 tt0 -46.25 -50.36 16.06 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 114.217 -1.356 . . . . 0.0 110.605 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.41 ' H ' ' HG ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -78.41 -22.18 48.16 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.274 -179.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.4 t -70.61 -19.67 21.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.453 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 14.3 m-30 -75.08 -24.03 58.09 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.83 -49.2 9.94 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.45 -33.39 69.67 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -61.47 -40.26 93.89 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.921 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.92 -48.59 57.94 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 124.567 1.167 . . . . 0.0 108.907 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 44.5 t -52.62 -53.2 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 124.652 1.22 . . . . 0.0 110.553 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 173.48 37.9 0.04 OUTLIER Glycine 0 N--CA 1.496 2.652 0 C-N-CA 119.898 -1.144 . . . . 0.0 112.942 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 78.3 p 42.52 27.67 0.1 Allowed 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -151.25 -70.12 0.17 Allowed 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 116.923 -1.513 . . . . 0.0 108.826 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 22.7 t70 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.99 -73.36 0.19 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.404 ' HA ' ' CE1' ' A' ' 6' ' ' HIS . 0.5 OUTLIER -172.49 21.32 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 179.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.424 ' C ' ' H ' ' A' ' 6' ' ' HIS . 9.2 p90 -104.96 -44.34 4.83 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.251 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.5 ttp85 -70.17 2.91 3.19 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 122.833 1.301 . . . . 0.0 113.176 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.424 ' H ' ' C ' ' A' ' 4' ' ' PHE . 17.2 m170 -76.12 -46.06 30.63 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 112.598 -2.092 . . . . 0.0 109.416 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -176.33 25.8 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 O-C-N 124.274 0.984 . . . . 0.0 112.009 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.9 t -161.59 45.68 0.17 Allowed 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.683 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.07 -41.62 0.05 OUTLIER Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -153.54 -166.46 2.41 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.448 ' C ' ' H ' ' A' ' 13' ' ' HIS . 0.9 OUTLIER -158.29 21.25 0.24 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 123.603 0.564 . . . . 0.0 112.057 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.0 t 72.49 -34.66 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 125.747 1.905 . . . . 0.0 112.027 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.448 ' H ' ' C ' ' A' ' 11' ' ' GLU . 6.5 m170 74.86 38.07 0.48 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -137.56 -79.54 0.37 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 112.909 -1.95 . . . . 0.0 107.231 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -51.77 -47.74 64.04 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.406 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.504 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 27.7 tt0 -49.64 -34.74 19.08 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.106 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 mt -81.41 -28.35 34.35 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 114.847 -1.069 . . . . 0.0 111.723 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.4 t -65.68 -26.92 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 C-N-CA 118.475 -1.29 . . . . 0.0 107.577 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.504 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 4.7 m-30 -71.37 -26.98 63.02 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 113.76 -1.564 . . . . 0.0 107.672 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -78.97 -47.99 15.31 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.86 -26.92 69.0 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -72.52 -22.7 60.99 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 118.714 -1.194 . . . . 0.0 111.763 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -99.22 -44.02 6.4 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 124.055 0.847 . . . . 0.0 113.193 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.9 t -102.72 -28.41 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 123.954 0.784 . . . . 0.0 112.24 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 41.23 61.19 2.11 Favored Glycine 0 N--CA 1.504 3.204 0 O-C-N 123.974 0.796 . . . . 0.0 113.142 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.9 p -149.07 -84.1 0.1 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 123.954 0.443 . . . . 0.0 110.607 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -81.69 -1.98 48.82 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 123.692 0.62 . . . . 0.0 111.055 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.415 ' HZ3' ' HB2' ' A' ' 28' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.503 2.215 0 CA-C-O 115.305 -2.283 . . . . 0.0 114.068 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.496 1.86 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 41.29 34.68 0.35 Allowed 'General case' 0 N--CA 1.509 2.517 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 48.04 18.84 0.16 Allowed 'General case' 0 N--CA 1.502 2.131 0 CA-C-N 114.603 -1.181 . . . . 0.0 114.093 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -65.91 -36.42 83.35 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.22 20.12 4.6 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 113.967 -1.469 . . . . 0.0 111.122 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -119.02 -51.87 2.33 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.431 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -130.67 35.12 4.04 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.2 p -176.68 34.4 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.234 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.492 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.47 76.72 0.03 OUTLIER Glycine 0 N--CA 1.494 2.534 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.466 ' CG ' ' N ' ' A' ' 11' ' ' GLU . 6.3 p90 -43.42 -40.78 3.92 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 121.339 0.59 . . . . 0.0 112.216 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.466 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 20.2 mt-10 39.11 106.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 126.043 2.089 . . . . 0.0 116.311 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.859 HG12 ' H ' ' A' ' 14' ' ' HIS . 44.3 t -126.93 -63.77 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-N 112.94 -1.936 . . . . 0.0 106.328 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.406 ' CD2' ' N ' ' A' ' 13' ' ' HIS . 12.1 m170 82.11 7.66 0.95 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 125.958 2.036 . . . . 0.0 112.024 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.859 ' H ' HG12 ' A' ' 12' ' ' VAL . 21.6 m-70 -104.68 -78.16 0.57 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 103.7 -2.704 . . . . 0.0 103.7 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -63.66 -17.67 63.17 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.658 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.641 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 32.0 tt0 -60.95 -48.59 81.1 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.596 -1.183 . . . . 0.0 110.621 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.04 -19.51 61.83 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.203 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.6 t -76.36 -41.79 36.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.868 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.641 ' CE2' ' HA ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -78.6 -19.79 51.95 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 125.28 1.613 . . . . 0.0 108.747 -179.595 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -79.91 -41.62 25.76 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.38 -33.67 74.68 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.407 ' HB3' ' HA ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -70.77 -27.56 64.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 124.938 1.399 . . . . 0.0 108.826 179.681 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -78.25 -54.33 6.34 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.894 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.1 t -78.16 -3.98 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 123.722 0.639 . . . . 0.0 110.466 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.02 74.45 0.34 Allowed Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.8 p 48.78 34.92 5.68 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 125.019 1.07 . . . . 0.0 111.124 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 58.14 61.52 2.3 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.494 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 116.779 -1.582 . . . . 0.0 110.444 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 120.714 0.292 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.72 -24.36 19.49 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.504 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 32.73 32.31 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 117.241 2.311 . . . . 0.0 117.241 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.465 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -74.35 14.19 0.48 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 113.11 -1.859 . . . . 0.0 110.277 179.563 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.409 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 10.0 mtm-85 55.81 27.56 11.06 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 122.75 1.262 . . . . 0.0 108.406 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.447 ' O ' ' CB ' ' A' ' 7' ' ' ASP . 17.4 m-70 52.88 17.08 0.8 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 111.213 -2.721 . . . . 0.0 111.093 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.447 ' CB ' ' O ' ' A' ' 6' ' ' HIS . 40.6 p-10 127.98 37.67 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.523 0 O-C-N 126.51 2.381 . . . . 0.0 111.647 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.409 ' HA ' ' HB2' ' A' ' 5' ' ' ARG . 4.1 p 59.59 32.8 21.8 Favored 'General case' 0 N--CA 1.506 2.372 0 CA-C-O 122.325 1.059 . . . . 0.0 110.916 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.12 68.7 0.15 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 105.473 -3.051 . . . . 0.0 105.473 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.71 167.19 7.69 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 114.079 1.141 . . . . 0.0 114.079 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.04 138.3 42.04 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 113.288 -1.778 . . . . 0.0 109.03 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.644 HG12 ' H ' ' A' ' 14' ' ' HIS . 42.5 t -153.86 -60.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.55 ' H ' ' HB3' ' A' ' 16' ' ' GLU . 8.3 m170 74.87 -18.28 0.44 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 125.748 1.905 . . . . 0.0 113.166 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.644 ' H ' HG12 ' A' ' 12' ' ' VAL . 11.6 m-70 -57.31 -43.28 83.14 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.506 0.669 . . . . 0.0 109.392 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.1 -30.61 2.42 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 113.242 -1.799 . . . . 0.0 106.661 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.55 ' HB3' ' H ' ' A' ' 13' ' ' HIS . 42.6 tt0 -50.32 -48.23 55.43 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.191 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -79.26 -20.45 48.1 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.469 -1.292 . . . . 0.0 110.738 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.5 t -70.49 -19.34 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.413 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 16.9 m-30 -72.41 -25.02 61.32 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -82.15 -48.2 11.6 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.07 -25.35 65.32 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.19 -38.47 60.8 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 125.331 1.644 . . . . 0.0 108.35 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.08 -48.04 75.16 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.5 t -70.02 -17.7 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.382 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.69 52.77 48.54 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.1 t 53.13 30.39 9.67 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 124.564 0.803 . . . . 0.0 111.19 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 72.61 56.12 0.14 Allowed 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.713 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.985 0 CA-C-N 113.268 -1.787 . . . . 0.0 107.881 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 120.918 0.389 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.11 -24.53 67.45 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.661 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 63.92 101.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 124.558 1.161 . . . . 0.0 110.513 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.405 ' HA ' ' CD1' ' A' ' 10' ' ' TYR . 1.1 p90 -163.89 -38.92 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 114.207 -1.36 . . . . 0.0 109.992 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.429 ' HA ' ' NE ' ' A' ' 5' ' ' ARG . 5.7 mmp_? -74.97 -9.8 58.88 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-O 122.602 1.191 . . . . 0.0 110.397 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -61.48 -22.93 65.53 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 111.686 -2.506 . . . . 0.0 109.164 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -141.09 19.92 2.28 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 114.616 -1.174 . . . . 0.0 109.729 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.4 t 47.37 44.5 16.35 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 114.126 -1.397 . . . . 0.0 111.659 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.39 55.18 0.3 Allowed Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.405 ' CD1' ' HA ' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -60.17 -179.78 0.12 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.95 162.62 29.28 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.288 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.422 ' O ' ' HB2' ' A' ' 13' ' ' HIS . 74.0 t -143.55 -54.46 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.592 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.422 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 15.1 m-70 78.64 24.66 0.57 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 126.231 2.207 . . . . 0.0 112.346 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -119.3 -94.07 0.51 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 101.726 -3.435 . . . . 0.0 101.726 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -62.74 -20.9 65.39 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.416 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 30.3 tt0 -47.93 -52.18 20.56 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.896 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.65 -16.68 55.32 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.766 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.9 t -72.19 -21.38 20.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.416 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 12.8 m-85 -75.95 -23.95 55.44 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -80.74 -47.7 13.58 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.45 ' HB1' ' ND2' ' A' ' 27' ' ' ASN . . . -58.34 -40.18 81.46 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.64 -36.99 80.03 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 113.489 -1.687 . . . . 0.0 109.828 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.05 -49.38 65.33 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.55 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.7 t -54.31 -53.98 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 124.42 1.075 . . . . 0.0 109.526 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.96 -35.9 2.53 Favored Glycine 0 N--CA 1.496 2.672 0 O-C-N 124.053 0.846 . . . . 0.0 112.807 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.0 m -57.59 -31.71 66.46 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.107 0.479 . . . . 0.0 111.181 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.45 ' ND2' ' HB1' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -107.37 -7.09 16.78 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.103 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.826 0 O-C-N 124.505 1.128 . . . . 0.0 109.355 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.58 -27.43 13.41 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 124.079 0.862 . . . . 0.0 111.141 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 36.19 32.29 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.44 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -75.96 24.91 0.12 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 113.684 -1.598 . . . . 0.0 112.944 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.6 mtp85 56.34 28.59 13.69 Favored 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.427 ' CG ' ' HG2' ' A' ' 11' ' ' GLU . 2.7 m170 56.26 53.97 8.26 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 112.789 -2.005 . . . . 0.0 106.49 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 64.43 36.7 8.71 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 113.318 -1.764 . . . . 0.0 111.19 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.7 m 62.53 64.82 0.89 Allowed 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 114.073 -1.421 . . . . 0.0 112.601 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.4 -83.06 0.16 Allowed Glycine 0 N--CA 1.484 1.888 1 N-CA-C 102.117 -4.393 . . . . 0.0 102.117 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -174.97 156.27 2.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 124.763 0.92 . . . . 0.0 109.899 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.427 ' HG2' ' CG ' ' A' ' 6' ' ' HIS . 18.8 mt-10 -134.04 109.14 8.77 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 122.206 1.003 . . . . 0.0 110.603 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.888 HG12 ' H ' ' A' ' 14' ' ' HIS . 41.7 t -129.14 -60.69 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-N 112.384 -2.189 . . . . 0.0 106.323 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.444 ' N ' ' CD2' ' A' ' 13' ' ' HIS . 6.8 m170 75.66 0.19 3.34 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 125.48 1.738 . . . . 0.0 111.943 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.888 ' H ' HG12 ' A' ' 12' ' ' VAL . 20.0 m-70 -93.81 -88.95 0.22 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -56.39 -27.05 55.13 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.455 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 24.4 tt0 -48.84 -48.03 42.11 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 114.072 -1.422 . . . . 0.0 109.151 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.51 -20.81 46.32 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 124.169 0.918 . . . . 0.0 111.858 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.7 t -70.27 -21.98 23.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.455 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 11.5 m-30 -74.39 -23.16 58.93 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -81.82 -44.19 17.26 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.35 -38.74 81.16 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -59.89 -36.9 77.93 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.525 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.59 -50.32 52.55 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.8 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.615 HG12 ' H ' ' A' ' 26' ' ' SER . 77.4 t -53.0 -56.54 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 124.55 1.157 . . . . 0.0 109.507 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.45 -1.24 0.3 Allowed Glycine 0 N--CA 1.499 2.839 0 O-C-N 124.073 0.858 . . . . 0.0 115.221 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.615 ' H ' HG12 ' A' ' 24' ' ' VAL . 47.7 m -75.63 -93.96 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -66.57 -18.97 65.66 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.6 mmtt . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 116.466 -1.731 . . . . 0.0 108.89 179.87 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.508 0.67 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.64 -16.77 63.44 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.151 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 54.81 18.09 2.01 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 124.686 1.241 . . . . 0.0 113.879 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -52.69 -58.6 6.3 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.06 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.419 ' H ' ' HD2' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -65.47 10.07 0.1 Allowed 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 116.792 2.145 . . . . 0.0 116.792 -179.637 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -92.37 -19.88 21.63 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -152.19 19.11 0.66 Allowed 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 114.418 -1.265 . . . . 0.0 108.827 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.0 t 53.03 25.1 3.84 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 121.874 0.845 . . . . 0.0 109.865 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 55.53 34.07 59.71 Favored Glycine 0 N--CA 1.497 2.702 0 CA-C-N 113.898 -1.501 . . . . 0.0 112.147 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.73 148.57 24.68 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 120.896 0.379 . . . . 0.0 110.921 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -141.49 128.82 21.13 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.501 HG12 ' H ' ' A' ' 14' ' ' HIS . 6.0 t -131.33 -62.23 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.067 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.536 ' O ' HD23 ' A' ' 17' ' ' LEU . 7.4 m170 77.3 -22.72 0.27 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 125.328 1.643 . . . . 0.0 110.795 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.501 ' H ' HG12 ' A' ' 12' ' ' VAL . 29.7 m-70 -75.17 -95.9 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.37 -27.23 62.11 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.484 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 29.2 tt0 -49.98 -46.15 52.26 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 113.889 -1.505 . . . . 0.0 108.955 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.536 HD23 ' O ' ' A' ' 13' ' ' HIS . 0.5 OUTLIER -78.52 -23.38 46.31 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.27 -0.972 . . . . 0.0 111.145 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.437 ' HA ' ' HB3' ' A' ' 21' ' ' ALA . 61.0 t -70.9 -17.15 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.484 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 15.0 m-30 -75.98 -15.6 60.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 124.437 1.085 . . . . 0.0 108.135 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -96.9 -48.53 5.4 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 18' ' ' VAL . . . -62.39 -16.52 55.23 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 114.038 -1.437 . . . . 0.0 107.403 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.46 -45.89 78.23 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -65.52 -48.07 73.78 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 114.007 -1.451 . . . . 0.0 107.969 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.5 t -59.23 -21.65 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.583 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.24 48.02 55.1 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 46.4 p 47.09 27.74 0.82 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 124.945 1.027 . . . . 0.0 112.828 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 54.28 62.38 2.6 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 114.757 -1.111 . . . . 0.0 110.884 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.9 mtpp . . . . . 0 N--CA 1.499 2.019 0 CA-C-O 116.311 -1.804 . . . . 0.0 111.169 179.935 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.49 -107.85 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -168.75 27.27 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 121.792 0.806 . . . . 0.0 109.429 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -56.2 -63.55 1.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.35 -1.296 . . . . 0.0 111.12 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.417 ' HD3' ' CD2' ' A' ' 6' ' ' HIS . 0.1 OUTLIER -75.88 17.8 0.3 Allowed 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -179.786 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.417 ' CD2' ' HD3' ' A' ' 5' ' ' ARG . 8.0 m-70 -107.39 -56.19 2.24 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 114.313 -1.312 . . . . 0.0 107.817 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -165.08 35.82 0.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.946 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.5 t -158.56 32.17 0.23 Allowed 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 121.332 0.587 . . . . 0.0 111.631 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 177.15 -30.9 0.08 OUTLIER Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -63.61 175.77 1.01 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.809 0.814 . . . . 0.0 112.42 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -153.15 148.76 27.31 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.772 HG12 ' H ' ' A' ' 14' ' ' HIS . 2.4 t -139.16 -50.59 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 124.042 0.839 . . . . 0.0 110.917 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.9 m170 73.73 -7.35 1.6 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 124.583 1.177 . . . . 0.0 112.651 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.772 ' H ' HG12 ' A' ' 12' ' ' VAL . 20.7 m-70 -95.46 -97.63 0.17 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 103.468 -2.79 . . . . 0.0 103.468 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -55.83 -23.48 30.72 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.506 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 34.4 tt0 -48.29 -44.0 33.32 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 114.063 -1.426 . . . . 0.0 110.978 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.411 ' H ' ' HG ' ' A' ' 17' ' ' LEU . 1.0 OUTLIER -85.46 -24.39 27.44 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.632 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.6 t -69.4 -16.65 20.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.506 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 19.3 m-30 -75.31 -22.9 57.34 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -83.94 -48.13 10.3 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.3 -27.56 68.57 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -63.15 -42.37 99.45 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.474 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.77 -47.84 73.84 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.639 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 82.6 t -51.74 -52.32 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 124.688 1.243 . . . . 0.0 109.427 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.82 25.93 1.47 Allowed Glycine 0 N--CA 1.496 2.661 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.8 m 42.09 22.83 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 50.59 29.47 4.11 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.419 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 116.129 -1.891 . . . . 0.0 111.526 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.37 -24.14 4.0 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.517 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 38.76 31.61 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 125.448 1.717 . . . . 0.0 112.587 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -121.32 79.29 1.51 Allowed 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 113.073 -1.876 . . . . 0.0 106.182 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 91.6 56.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 111.148 -2.751 . . . . 0.0 106.112 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 58.0 46.32 16.63 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 112.225 -2.261 . . . . 0.0 107.065 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.5 t0 76.68 38.02 0.29 Allowed 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 113.355 -1.748 . . . . 0.0 110.212 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.1 m 64.63 75.73 0.36 Allowed 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 122.872 1.32 . . . . 0.0 110.256 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.35 -16.72 78.75 Favored Glycine 0 N--CA 1.491 2.313 0 CA-C-N 112.04 -2.345 . . . . 0.0 109.667 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -74.51 168.76 19.1 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 124.169 0.57 . . . . 0.0 111.009 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.23 26.36 0.1 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 118.045 2.609 . . . . 0.0 118.045 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.697 HG12 ' CD2' ' A' ' 14' ' ' HIS . 45.0 t 72.59 -58.27 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 125.525 1.766 . . . . 0.0 112.268 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 11.9 m170 90.41 -5.42 0.31 Allowed 'General case' 0 N--CA 1.505 2.281 0 O-C-N 126.336 2.273 . . . . 0.0 113.574 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.697 ' CD2' HG12 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -124.77 -65.86 1.01 Allowed 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.702 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.597 ' HB2' HG11 ' A' ' 12' ' ' VAL . 1.6 mp0 -54.37 -27.5 36.84 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.621 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.631 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 25.9 tt0 -64.29 -45.08 89.55 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.053 -1.059 . . . . 0.0 109.456 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.6 -20.95 62.71 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.832 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.9 t -75.14 -45.9 40.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.694 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.631 ' CE2' ' HA ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -76.25 -19.05 58.69 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.228 -1.351 . . . . 0.0 108.959 -179.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.595 ' O ' HG23 ' A' ' 24' ' ' VAL . 84.8 t80 -80.52 -39.43 27.86 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.4 -42.7 95.96 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.64 -35.39 76.07 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 113.628 -1.624 . . . . 0.0 109.524 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.16 -51.72 50.24 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.512 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 20' ' ' PHE . 38.5 t -51.74 -50.22 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 124.129 0.893 . . . . 0.0 109.784 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.17 41.02 9.67 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.0 p -131.12 -34.5 1.44 Allowed 'General case' 0 N--CA 1.499 1.975 0 CA-C-N 114.22 -0.99 . . . . 0.0 109.203 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.503 ' H ' ' ND2' ' A' ' 27' ' ' ASN . 0.0 OUTLIER -113.71 -17.46 12.1 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 113.315 -1.766 . . . . 0.0 108.571 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp . . . . . 0 N--CA 1.498 1.942 0 CA-C-O 114.788 -2.529 . . . . 0.0 110.96 179.94 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.9 t0 . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.83 -16.72 64.08 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.772 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 54.95 23.12 4.79 Favored 'General case' 0 N--CA 1.504 2.244 0 CA-C-O 122.69 1.233 . . . . 0.0 112.298 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.589 ' H ' ' NH2' ' A' ' 5' ' ' ARG . 20.6 t80 -53.43 -39.01 64.05 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 112.474 -2.148 . . . . 0.0 110.913 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.589 ' NH2' ' H ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -76.77 17.55 0.41 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 123.877 0.735 . . . . 0.0 112.887 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.408 ' H ' ' C ' ' A' ' 4' ' ' PHE . 11.2 m80 -131.16 -58.69 1.0 Allowed 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.785 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -85.19 9.27 15.55 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.345 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.0 t -170.53 24.69 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 113.361 -1.745 . . . . 0.0 108.811 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.55 -42.46 6.49 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -56.34 151.48 12.87 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 114.357 -0.921 . . . . 0.0 110.884 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -76.77 138.91 40.19 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 124.254 0.971 . . . . 0.0 110.497 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.454 HG12 ' H ' ' A' ' 14' ' ' HIS . 94.4 t -127.18 -56.68 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 113.219 -1.809 . . . . 0.0 107.569 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.43 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 12.0 m170 89.41 -2.25 0.36 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 126.852 2.595 . . . . 0.0 110.524 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.454 ' H ' HG12 ' A' ' 12' ' ' VAL . 21.6 m-70 -100.9 -98.21 0.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 103.549 -2.76 . . . . 0.0 103.549 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -53.87 -25.2 18.7 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.481 ' HA ' ' CD2' ' A' ' 19' ' ' PHE . 29.1 tt0 -46.73 -47.71 20.55 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.139 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.434 ' H ' ' HG ' ' A' ' 17' ' ' LEU . 1.0 OUTLIER -82.98 -24.45 32.93 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.296 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.9 t -68.88 -18.7 23.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.481 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 17.9 m-85 -74.83 -23.65 58.48 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -84.71 -48.39 9.49 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.56 -34.58 71.21 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -57.6 -42.58 83.51 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.075 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.68 -51.9 50.88 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.392 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.3 t -51.78 -51.61 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 124.726 1.266 . . . . 0.0 111.038 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -38.22 101.23 0.01 OUTLIER Glycine 0 N--CA 1.498 2.786 0 O-C-N 124.337 1.023 . . . . 0.0 113.583 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.8 t 40.23 36.51 0.33 Allowed 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 114.394 -0.903 . . . . 0.0 113.331 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.9 p30 40.64 31.62 0.12 Allowed 'General case' 0 N--CA 1.504 2.248 0 O-C-N 124.354 1.034 . . . . 0.0 113.659 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt . . . . . 0 N--CA 1.502 2.126 0 CA-C-O 117.936 -1.031 . . . . 0.0 113.109 -179.883 . . . . . . . . 0 0 . 1 stop_ save_